SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1997
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission File Number 1-5721
LEUCADIA NATIONAL CORPORATION
(Exact name of registrant as specified in its Charter)
New York 13-2615557
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
315 Park Avenue South, New York, New York 10010-3607
(Address of principal executive offices) (Zip Code)
(212) 460 -1900
(Registrant's telephone number, including area code)
N/A
(Former name, former address and former fiscal year,
if changed since last report)
----------------------------
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
YES [X] NO [ ]
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS
Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court.
YES [ ] NO [ ]
APPLICABLE ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding
of each of the issuer's classes of common stock, at August 6, 1997: 63,801,297.
<PAGE>
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS.
LEUCADIA NATIONAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
June 30, 1997 and December 31, 1996
(Dollars in thousands, except par value)
<TABLE>
<CAPTION>
June 30, December 31,
1997 1996
----------- ------------
(Unaudited)
<S> <C> <C>
ASSETS
Investments:
Available for sale (aggregate cost of $2,190,162 and $1,926,201) $2,186,398 $1,928,938
Trading securities (aggregate cost of $45,142 and $32,317) 45,039 31,030
Held to maturity (aggregate fair value of $63,539 and $68,198) 63,626 68,202
Policyholder loans 4,898 4,955
Other investments, including accrued interest income 50,958 68,059
---------- ----------
Total investments 2,350,919 2,101,184
Cash and cash equivalents 259,308 299,472
Reinsurance receivable, net 246,657 246,946
Trade, notes and other receivables, net 565,543 456,088
Prepaids and other assets 194,123 222,141
Property, equipment and leasehold improvements, net 89,392 89,640
Deferred policy acquisition costs 42,521 41,654
Deferred income taxes 72,117 81,102
Separate and variable accounts 507,603 436,992
Investments in associated companies 207,874 206,384
Net assets of discontinued operations 151,180 149,758
---------- ----------
Total $4,687,237 $4,331,361
========== ==========
LIABILITIES
Customer banking deposits $ 200,170 $ 209,261
Trade payables and expense accruals 165,552 187,561
Other liabilities 129,242 120,753
Income taxes payable 50,603 42,240
Policy reserves 1,251,119 1,253,445
Unearned premiums 455,677 431,323
Separate and variable accounts 507,603 435,937
Debt, including current maturities 579,384 523,366
---------- ----------
Total liabilities 3,339,350 3,203,886
---------- ----------
Minority interest 9,517 9,368
---------- ----------
Company-obligated mandatorily redeemable preferred securities of
subsidiary trust holding solely Company securities 150,000 -
---------- ----------
SHAREHOLDERS' EQUITY
Common shares, par value $1 per share, authorized 150,000,000 shares; 61,552,990
and 60,417,579 shares issued and outstanding, after deducting
54,360,980 and 54,353,691 shares held in treasury 61,553 60,418
Additional paid-in capital 190,674 161,026
Net unrealized gain (loss) on investments (5,030) 1,759
Retained earnings 941,173 894,904
---------- ----------
Total shareholders' equity 1,188,370 1,118,107
---------- ----------
Total $4,687,237 $4,331,361
========== ==========
</TABLE>
See notes to interim consolidated financial statements.
-2-
<PAGE>
LEUCADIA NATIONAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
For the periods ended June 30, 1997 and 1996
(In thousands, except per share amounts)
(Unaudited)
<TABLE>
<CAPTION>
For the Three Month For the Six Month
Period Ended June 30, Period Ended June 30,
--------------------- ---------------------
1997 1996 1997 1996
---- ---- ---- ----
<S> <C> <C> <C> <C>
REVENUES:
Insurance revenues and commissions $202,058 $211,480 $405,193 $423,668
Manufacturing 34,619 40,208 70,570 78,585
Finance 10,252 12,701 20,861 26,012
Investment and other income 106,418 57,349 176,120 116,723
Net securities gains (losses) (433) 3,259 1,739 10,320
Equity in losses of associated companies (9,382) (5,325) (20,393) (5,703)
-------- -------- -------- --------
343,532 319,672 654,090 649,605
-------- -------- -------- --------
EXPENSES:
Provision for insurance losses and policy benefits 179,105 184,321 354,517 365,972
Amortization of deferred policy acquisition costs 20,434 24,066 41,918 49,633
Manufacturing cost of goods sold 24,251 29,583 49,253 57,947
Interest 11,822 13,368 24,780 27,247
Salaries 20,286 19,555 39,639 39,508
Selling, general and other expenses 41,466 45,507 85,528 95,507
-------- -------- -------- --------
297,364 316,400 595,635 635,814
-------- -------- -------- --------
Income from continuing operations before income taxes, minority expense of
trust preferred securities and extraordinary loss 46,168 3,272 58,455 13,791
-------- -------- -------- --------
Income taxes:
Current 9,001 2,892 10,716 4,259
Deferred 7,833 (3,646) 10,897 (1,878)
-------- -------- -------- --------
16,834 (754) 21,613 2,381
-------- -------- -------- --------
Income from continuing operations before minority
expense of trust preferred securities and extraordinary loss 29,334 4,026 36,842 11,410
Minority expense of trust preferred securities, net of taxes 2,109 - 3,866 -
-------- -------- -------- --------
Income from continuing operations before extraordinary loss 27,225 4,026 32,976 11,410
Income from discontinued operations, net of taxes 8,368 9,147 15,337 17,364
-------- -------- -------- --------
Income before extraordinary loss 35,593 13,173 48,313 28,774
Extraordinary loss from early extinguishment of debt, net of
income tax benefit of $1,100 (2,044) - (2,044) -
-------- -------- -------- --------
Net income $ 33,549 $ 13,173 $ 46,269 $ 28,774
======== ======== ======== ========
Earnings (loss) per common and dilutive common equivalent share:
Income from continuing operations before extraordinary loss $ .44 $ .07 $ .54 $ .19
Income from discontinued operations .14 .15 .25 .29
Extraordinary loss (.03) - (.03) -
----- ----- ----- -----
Net income $ .55 $ .22 $ .76 $.48
===== ===== ===== =====
Fully diluted earnings (loss) per common share:
Income from continuing operations before extraordinary loss $ .43 $ .07 $ .54 $ .19
Income from discontinued operations .13 .15 .24 .29
Extraordinary loss (.03) - (.03) -
----- ----- ----- -----
Net income $ .53 $ .22 $ .75 $ .48
===== ===== ===== =====
</TABLE>
See notes to interim consolidated financial statements.
-3-
<PAGE>
LEUCADIA NATIONAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the six months ended June 30, 1997 and 1996
(Unaudited)
<TABLE>
<CAPTION>
1997 1996
---- ----
(Thousands of dollars)
<S> <C> <C>
NET CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 46,269 $ 28,774
Adjustments to reconcile net income to net cash (used for) operations:
Extraordinary loss, net of income tax benefit 2,044 -
Provision (benefit) for deferred income taxes 10,897 (1,878)
Depreciation and amortization of property, equipment and leasehold improvements 7,959 8,794
Other amortization 44,337 53,709
Provision for doubtful accounts 6,367 7,895
Net securities (gains) (1,739) (10,320)
(Gain) on disposal of real estate, property and equipment (56,532) (2,436)
Equity in losses of associated companies 20,393 5,703
Minority expense of trust preferred securities, net of taxes 3,866 -
Purchases of investments classified as trading (94,341) (83,279)
Proceeds from sales of investments classified as trading 76,520 83,176
Deferred policy acquisition costs incurred and deferred (42,785) (51,829)
Net change in:
Reinsurance receivables 289 19,255
Trade, notes and other receivables (131,467) (53,839)
Prepaids and other assets (51,515) (32,961)
Net assets of discontinued operations (196) 1,050
Trade payables and expense accruals (20,917) (6,799)
Other liabilities 7,930 21,773
Income taxes payable 8,337 440
Policy reserves (2,326) (29,269)
Unearned premiums 24,354 39,834
Other 1,189 (630)
----------- ---------
Net cash (used for) operating activities (141,067) (2,837)
----------- ---------
NET CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of real estate, property, equipment and leasehold improvements (36,848) (14,516)
Proceeds from disposals of real estate, property and equipment 139,168 15,879
Advances on loan receivables (53,186) (68,581)
Principal collections on loan receivables 61,771 71,382
Purchases of investments (other than short-term) (1,049,024) (832,062)
Proceeds from maturities of investments 281,825 302,238
Proceeds from sales of investments 535,202 625,525
----------- ---------
Net cash provided by (used for) investing activities (121,092) 99,865
----------- ---------
NET CASH FLOWS FROM FINANCING ACTIVITIES:
Net change in short-term borrowings 113,488 322
Net change in customer banking deposits (9,039) 7,983
Issuance of Company-obligated mandatorily redeemable preferred securities of subsidiary trust 147,465 -
Issuance of long-term debt, net of issuance costs - 8,799
Reduction of long-term debt (29,919) (29,377)
----------- ---------
Net cash provided by (used for) financing activities 221,995 (12,273)
----------- ---------
Net (decrease) increase in cash and cash equivalents (40,164) 84,755
Cash and cash equivalents at January 1, 299,472 206,729
----------- ---------
Cash and cash equivalents at June 30, $ 259,308 $ 291,484
=========== =========
</TABLE>
See notes to interim consolidated financial statements.
-4-
<PAGE>
LEUCADIA NATIONAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
For the six months ended June 30, 1997 and 1996
(Unaudited)
<TABLE>
<CAPTION>
Net
Common Unrealized
Shares Additional Gain
$1 Par Paid-In (Loss) on Retained
Value Capital Investments Earnings Total
---------- ----------- ----------- ----------- ----------
(Thousands of dollars)
<S> <C> <C> <C> <C> <C>
BALANCE, JANUARY 1, 1996 $60,164 $159,914 $ 30,086 $861,327 $1,111,491
Exercise of options to purchase
common shares 177 1,144 1,321
Purchase of stock for treasury (24) (552) (576)
Net change in unrealized gain (loss)
on investments (38,608) (38,608)
Net income 28,774 28,774
------- -------- -------- -------- ----------
BALANCE, JUNE 30, 1996 $60,317 $160,506 $ (8,522) $890,101 $1,102,402
======= ======== ======== ======== ==========
BALANCE, JANUARY 1, 1997 $60,418 $161,026 $ 1,759 $894,904 $1,118,107
Exercise of options to purchase
common shares 110 1,184 1,294
Conversion of 5 1/4% Convertible
Subordinated Debentures 1,033 28,669 29,702
Purchase of stock for treasury (8) (205) (213)
Net change in unrealized gain (loss)
on investments (6,789) (6,789)
Net income 46,269 46,269
------- -------- -------- -------- ----------
BALANCE, JUNE 30, 1997 $61,553 $190,674 $ (5,030) $941,173 $1,188,370
======= ======== ======== ======== ==========
</TABLE>
See notes to interim consolidated financial statements.
-5-
<PAGE>
LEUCADIA NATIONAL CORPORATION AND SUBSIDIARIES
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
1. The unaudited interim consolidated financial statements, which reflect
all adjustments (consisting only of normal recurring items) that
management believes necessary to present fairly results of interim
operations, should be read in conjunction with the Notes to Consolidated
Financial Statements (including the Summary of Significant Accounting
Policies) included in the Company's audited consolidated financial
statements for the year ended December 31, 1996, which are included in
the Company's Annual Report filed on Form 10-K for such year (the "1996
10-K"). Results of operations for interim periods are not necessarily
indicative of annual results of operations. The consolidated balance
sheet at December 31, 1996 was extracted from the audited annual
financial statements and does not include all disclosures required by
generally accepted accounting principles for annual financial statements.
On April 30, 1997, the Company signed an agreement to sell its
subsidiaries, Colonial Penn Life Insurance Company and Providential Life
Insurance Company and certain related assets, including its health
insurance operations, to Conseco, Inc. for $460,000,000, including
$400,000,000 in notes secured by non-cancelable letters of credit and
$60,000,000 in cash. These companies are principally engaged in the sale
of graded benefit life insurance policies through direct marketing and
agent-sold Medicare supplement insurance. The sale is subject to
customary terms and conditions, including the receipt of regulatory
approvals, and is expected to close in the third quarter of 1997. The
Company expects to report a pre-tax gain of approximately $300,000,000
upon consummation of the transaction. The operations of these companies
have been classified as discontinued operations and prior periods'
financial statements have been restated to conform with this
presentation. See Note 6 below for additional information.
Certain amounts for prior periods have been reclassified to be consistent
with the 1997 presentation.
2. On June 30, 1997, the Company signed an agreement to sell the property
and casualty insurance business of the Colonial Penn P&C Group to General
Electric Capital Corporation for $950,000,000 in cash, plus an aggregate
of $156,164 per day from and including January 1, 1997 through and
including the closing date. The Group's primary business is providing
private passenger automobile insurance to the mature adult population
through direct response marketing. The transaction is subject to the
Company's shareholder approval, regulatory approvals and customary
closing conditions and is expected to close in the fourth quarter of
1997. The Company expects to report a pre-tax gain of approximately
$600,000,000 upon consummation of the transaction. Upon shareholder
approval of the transaction, the operations of the Group will be
classified as discontinued operations. The Colonial Penn P&C Group had
revenues of $303,100,000 and $301,100,000 for the six month periods ended
June 30, 1997 and 1996, respectively, and $153,100,000 and $147,600,000
for the three month periods ended June 30, 1997 and 1996, respectively.
Pre-tax income for the Group was $31,800,000 and $36,800,000 for the six
month periods ended June 30, 1997 and 1996, respectively, and $12,500,000
and $14,900,000 for the three month periods ended June 30, 1997 and 1996,
respectively. At June 30, 1997 and December 31, 1996, the Colonial Penn
P&C Group had total assets of $1,410,000,000 and $1,370,000,000,
respectively.
3. In January 1997, the Company sold $150,000,000 aggregate liquidation
amount of 8.65% trust issued preferred securities of its wholly-owned
subsidiary, Leucadia Capital Trust I, (the "Trust"). These
Company-obligated mandatorily redeemable preferred securities have an
effective maturity date of January 15, 2027 and represent undivided
beneficial interests in the Trust's assets, which consist solely of
$154,640,000 principal amount of 8.65% Junior Subordinated Deferrable
Interest Debentures due 2027 of the Company. Considered together, the
"back-up undertakings" of the Company related to the Trust's preferred
securities constitute a full and unconditional guarantee by the Company
of the Trust's obligations under the preferred securities.
-6-
<PAGE>
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED:
4. On March 12, 1997, the Company called for redemption on April 11, 1997
all of its outstanding $100,000,000 5 1/4% Convertible Subordinated
Debentures due 2003 (the "5 1/4% Debentures"), at a redemption price of
102.625% of the principal amount of the Debentures, plus accrued interest
through April 11, 1997. The redemption date, but not the interest accrual
period, was subsequently extended through July 11, 1997. As of June 30,
1997, $29,702,000 par value of the 5 1/4% Debentures was converted into
1,033,038 Common Shares and $5,528,000 par value of the 5 1/4% Debentures
was redeemed. From July 1, 1997 through the redemption date, an
additional $63,973,000 par value of the 5 1/4% Debentures was converted
into 2,225,107 Common Shares and an additional $797,000 par value of the
5 1/4% Debentures was redeemed. The funds used for these redemptions were
primarily derived from borrowings under the Company's credit facility.
Had all of the shares which were issued upon conversion of the 5 1/4%
Debentures been issued as of January 1, 1997, primary earnings per share
from continuing operations would have been $.52 and primary earnings per
share from discontinued operations would have been $.24 for the six month
period ended June 30, 1997.
5. On June 30, 1997, the Company sold its investment in a New York City
office building for $100,000,000 in cash. The Company reported a pre-tax
gain of approximately $35,600,000 on the sale.
6. The components of net assets of discontinued operations included in the
consolidated balance sheets are as follows (in thousands):
June 30, December 31,
1997 1996
---------- ----------
Investments $ 660,568 $ 688,936
Cash and cash equivalents 101,798 87,335
Separate account assets 114,419 109,082
Deferred policy acquisition costs 69,591 64,013
Other 60,564 62,967
---------- ----------
Total assets 1,006,940 1,012,333
---------- ----------
Policy reserves 683,473 687,200
Separate account liabilities 114,419 109,082
Other 57,868 66,293
---------- ----------
Total liabilities 855,760 862,575
---------- ----------
Net assets of discontinued operations $ 151,180 $ 149,758
========== ==========
A summary of the results of discontinued operations is as follows for the
six and three month periods ended June 30, 1997 and 1996 (in thousands):
<TABLE>
<CAPTION>
For the Three Month For the Six Month
Period Ended June 30, Period Ended June 30,
--------------------- ---------------------
1997 1996 1997 1996
---- ---- ---- ----
<S> <C> <C> <C> <C>
Revenues $58,724 $58,961 $119,981 $113,534
------- ------- -------- --------
Expenses:
Provision for insurance losses and policy benefits 34,847 34,559 74,802 66,883
Other operating expenses 11,013 10,330 21,594 20,020
------- ------- -------- --------
45,860 44,889 96,396 86,903
------- ------- -------- --------
Income before income taxes 12,864 14,072 23,585 26,631
Income taxes 4,496 4,925 8,248 9,267
------- ------- -------- --------
Income from discontinued operations, net of taxes $ 8,368 $ 9,147 $ 15,337 $ 17,364
======= ======= ======== ========
</TABLE>
-7-
<PAGE>
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED:
7. Earnings (loss) per common and dilutive common equivalent share were
calculated by dividing net income by the sum of the weighted average
number of common shares outstanding and the incremental weighted average
number of shares issuable upon exercise of outstanding options for the
periods they were outstanding. The number of shares used to calculate
primary earnings (loss) per share amounts was 61,001,000 and 60,569,000
for the six months periods ended June 30, 1997 and 1996, respectively,
and 61,303,000 and 60,552,000 for the three month periods ended June 30,
1997 and 1996, respectively.
Fully diluted earnings (loss) per share were calculated as described
above and, for 1997 also assumes the outstanding 5 1/4% Debentures had
been converted into Common Shares and earnings increased for the interest
on such debentures, net of the income tax effect. Conversion was not
assumed for the 1996 periods since the effect of such assumed conversion
would have been to increase earnings per share. The number of shares used
to calculate fully diluted earnings (loss) per share was 64,124,000 and
60,569,000 for the six month periods ended June 30, 1997 and 1996,
respectively, and 64,140,000 and 60,552,000 for the three month periods
ended June 30, 1997 and 1996, respectively.
8. Cash paid for interest and income taxes (net of refunds) was $26,803,000
and $5,210,000 respectively, for the six month period ended June 30, 1997
and $29,281,000 and $3,756,000, respectively, for the six month period
ended June 30, 1996.
-8-
<PAGE>
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF INTERIM OPERATIONS.
The following should be read in conjunction with the Management's Discussion and
Analysis of Financial Condition and Results of Operations included in the 1996
10-K.
LIQUIDITY AND CAPITAL RESOURCES
For the six month period ended June 30, 1997, net cash was used for operations,
principally to fund its capital commitments and bridge financing to Pepsi
International Bottlers ("PIB") and to advance amounts to the trustee to fund the
maximum redemption of the 5 1/4% Convertible Subordinated Debentures due 2003
(the "5 1/4% Debentures"). For the six month period ended June 30, 1996, net
cash was used for operations, principally to settle the Proposition 103
liability and to reinsure a block of single premium deferred annuity business.
In April 1996, the Company formed a joint venture, PIB, with PepsiCo, Inc. to be
the exclusive bottler and distributor of PepsiCo beverages in a large portion of
central and eastern Russia, Kyrgyzstan and Kazakstan. The Company and PepsiCo
have committed to make capital contributions to PIB of $79,500,000 and
$26,500,000, respectively. As of December 31, 1996, the Company contributed
$51,000,000; the balance was funded in January 1997. After reflecting its share
of losses since inception, the book value of the Company's investment was
$44,653,000 at June 30, 1997.
In July 1997, the Company, PepsiCo and PIB entered into loan agreements with
third party lenders to provide $90,000,000 of additional financing to PIB.
Actual funding will require, among other things, a license from the Russian
Central Bank. Pending satisfaction of such requirements, bridge financing to PIB
to cover operating costs and capital expenditures will be necessary. The Company
estimates that its share of the bridge financing should not exceed $52,500,000,
of which $37,500,000 was provided as of June 30, 1997. Although the Company
expects the financing from third party lenders will replace the Company's bridge
financing, PIB may need additional funds from its joint venture partners while
it is developing its business. Such amounts, if necessary, are not determinable
at this time.
In January 1997, the Company sold $150,000,000 aggregate liquidation amount of
8.65% trust issued preferred securities of its wholly-owned subsidiary, Leucadia
Capital Trust I (the "Trust"). These Company-obligated mandatorily redeemable
preferred securities have an effective maturity date of January 15, 2027 and
represent undivided beneficial interests in the Trust's assets, which consist
solely of $154,640,000 principal amount of 8.65% Junior Subordinated Deferrable
Interest Debentures due 2027 of the Company. Considered together, the "back-up
undertakings" of the Company related to the Trust's preferred securities
constitute a full and unconditional guarantee by the Company of the Trust's
obligations under the preferred securities.
On March 12, 1997, the Company called for redemption on April 11, 1997 all of
its outstanding $100,000,000 5 1/4% Debentures, at a redemption price of
102.625% of the principal amount of the Debentures, plus accrued interest
through April 11, 1997. The redemption date, but not the interest accrual
period, was subsequently extended through July 11, 1997. As of June 30, 1997,
$29,702,000 par value of the 5 1/4% Debentures was converted into 1,033,038
Common Shares and $5,528,000 par value of the 5 1/4% Debentures was redeemed.
From July 1, 1997 through the redemption date, an additional $63,973,000 par
value of the 5 1/4% Debentures was converted into 2,225,107 Common Shares and an
additional $797,000 par value of the 5 1/4% Debentures was redeemed. The funds
used for these redemptions were primarily derived from borrowings under the
Company's credit facility.
In June 1997, the Company also redeemed all of the aggregate principal amount
outstanding of its 10 3/8% Senior Subordinated Notes due June 15, 2002 for a
total redemption price of $23,112,000.
The Company utilized $163,300,000 of its bank credit agreement facility as of
June 30, 1997, principally to fund the maximum redemption of the 5 1/4%
Debentures. Of this amount, $128,300,000 was repaid through August 6, 1997
primarily from proceeds from the sale of the real estate investment described
below.
-9-
<PAGE>
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF INTERIM OPERATIONS, CONTINUED.
On April 30, 1997, the Company signed an agreement to sell its subsidiaries,
Colonial Penn Life Insurance Company and Providential Life Insurance Company and
certain related assets, including its health insurance operations, to Conseco,
Inc. for $460,000,000, including $400,000,000 in notes secured by non-cancelable
letters of credit and $60,000,000 in cash. These companies are principally
engaged in the sale of graded benefit life insurance policies through direct
marketing and agent-sold Medicare supplement insurance. The sale is subject to
customary terms and conditions, including the receipt of regulatory approvals,
and is expected to close in the third quarter of 1997. The Company expects to
report a pre-tax gain of approximately $300,000,000 upon consummation of the
transaction.
On June 30, 1997, the Company signed an agreement to sell the property and
casualty insurance business of the Colonial Penn P&C Group to General Electric
Capital Corporation for $950,000,000 in cash, plus an aggregate of $156,164 per
day from and including January 1, 1997 through and including the closing date.
The Group's primary business is providing private passenger automobile insurance
to the mature adult population through direct response marketing. The
transaction is subject to the Company's shareholder approval, regulatory
approvals and customary closing conditions and is expected to close in the
fourth quarter of 1997. The Company expects to report a pre-tax gain of
approximately $600,000,000 upon consummation of the transaction. The Colonial
Penn P&C Group had revenues of $303,100,000 and $301,100,000 for the six month
periods ended June 30, 1997 and 1996, respectively, and $153,100,000 and
$147,600,000 for the three month periods ended June 30, 1997 and 1996,
respectively. Pre-tax income for the Group was $31,800,000 and $36,800,000 for
the six month periods ended June 30, 1997 and 1996, respectively, and
$12,500,000 and $14,900,000 for the three month periods ended June 30, 1997 and
1996, respectively. At June 30, 1997 and December 31, 1996, the Colonial Penn
P&C Group had total assets of $1,410,000,000 and $1,370,000,000, respectively.
On June 30, 1997, the Company sold its investment in a New York City office
building for $100,000,000 in cash. The Company reported a pre-tax gain of
approximately $35,600,000 on the sale.
As more fully described in the 1996 10-K, securities classified as "available
for sale" are carried at fair value with unrealized gains and losses reflected
as a separate component of shareholders' equity, net of taxes. Principally as a
result of changes in market interest rates during 1997, the unrealized gain on
investments at the end of 1996 decreased to an unrealized loss of $5,030,000 as
of June 30, 1997. While this has resulted in a decrease in shareholders' equity
and book value per share, it had no effect on results of operations or cash
flows.
RESULTS OF OPERATIONS
THE 1997 PERIODS COMPARED TO THE 1996 PERIODS
Earned premium revenues of the Colonial Penn P&C Group were $256,051,000 and
$252,708,000 for the six month periods ended June 30, 1997 and 1996,
respectively, and $129,886,000 and $126,011,000 for the three month periods
ended June 30, 1997 and 1996, respectively. Earned premiums from voluntary
automobile policies were 17.9% higher during the six month period ended June 30,
1997 as compared to the six month period ended June 30, 1996, and voluntary
automobile policies in force at June 30, 1997 increased 4.9% from December 31,
1996. This growth in voluntary automobile business was partially offset by the
continued depopulation of state assigned risk automobile pools and reduced
service fee business.
Earned premium revenues and commissions of the Empire Group were $146,820,000
and $168,913,000 for the six month periods ended June 30, 1997 and 1996,
respectively, and $71,024,000 and $84,376,000 for the three month periods ended
June 30, 1997 and 1996, respectively. The decrease in earned premiums
principally relates to the depopulation of the assigned risk automobile pools
and reduced volume in certain commercial lines resulting from tighter
underwriting standards and increased competition.
-10-
<PAGE>
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF INTERIM OPERATIONS, CONTINUED.
The Company's loss ratios for its property and casualty operations were as
follows:
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
------------------ ------------------
1997 1996 1997 1996
---- ---- ---- ----
<S> <C> <C> <C> <C>
Loss Ratio:
GAAP 89.1% 87.5% 87.9% 86.7%
SAP 88.3% 86.1% 86.9% 84.5%
Expense Ratio:
GAAP 18.7% 17.2% 17.4% 17.8%
SAP 17.3% 15.7% 16.4% 16.0%
Combined Ratio:
GAAP 107.8% 104.7% 105.3% 104.5%
SAP 105.6% 101.8% 103.3% 100.5%
</TABLE>
The combined ratios of the Colonial Penn P&C Group increased primarily due to
increased levels of new voluntary automobile business for which higher loss
reserves are provided than on renewal business and an unusually high guarantee
association assessment. The combined ratios of the Empire Group increased
primarily due to reserve strengthening for prior accident years in the
commercial multiple peril and commercial automobile lines of business, higher
loss reserves provided on assigned risk business and increased levels of new
voluntary automobile business. This increase in the combined ratios was
partially offset by reduced expenses reflecting certain unusual expense charges
which were recorded during the six month period ended June 30, 1996. The
difference between the SAP and GAAP combined ratios principally reflects
accounting for certain expenses that are treated differently under SAP and GAAP
and, in the 1996 periods, an adjustment to SAP reinsurance reserves.
Although manufacturing revenues decreased in the 1997 periods principally due to
the disposal of certain non-performing businesses in 1996, the manufacturing
segment reported operating profits in 1997 as compared to operating losses in
1996, primarily due to these dispositions.
Finance revenues and operating profits reflect the level of consumer instalment
loans. Such loans approximated $216,752,000 at June 30, 1997 and $233,351,000 at
December 31, 1996. The decrease in finance revenues was partially offset by
decreased losses on automobile loans. The Company expects that the increased
level of competition in its automobile lending business will continue and,
together with the Company's tightened underwriting standards and the generally
lower rates being offered by competitors, is likely to result in a further
contraction in the size of this portfolio.
Investment and other income increased in 1997 as compared to 1996 principally
due to gains from sales of real estate properties of approximately $55,420,000
and $4,282,000 for the six month periods ended June 30, 1997 and 1996,
respectively, and $47,439,000 and $1,515,000 for the three month periods ended
June 30, 1997 and 1996, respectively, and higher investment yields on a larger
portfolio.
Equity in losses of associated companies increased in 1997 primarily due to
start-up losses from the Company's equity investment in PIB of $17,570,000 and
$2,780,000 for the six month periods ended June 30, 1997 and 1996, respectively,
and $9,060,000 and $2,780,000 for the three month periods ended June 30, 1997
and 1996, respectively. The Company anticipates that PIB will continue to
experience operating losses during the period that PIB is building production,
distribution capacity and market share. This loss was offset by decreased losses
from the Company's investment in MK Gold Company of $200,000 and $3,900,000 for
the six month periods ended June 30, 1997 and 1996, respectively and $100,000
and $3,700,000, for the three month periods ended June 30, 1997 and 1996,
respectively.
-11-
<PAGE>
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF INTERIM OPERATIONS, CONTINUED.
Interest expense primarily reflects the level of external borrowings outstanding
during the period.
The decrease in selling, general and other expenses in the 1997 periods as
compared to the 1996 periods principally reflects decreased expenses from the
disposition of certain manufacturing businesses, decreased operating expenses of
real estate properties, decreased expenses relating to certain investment
activities, including exploring investment opportunities in Russia, and lower
provisions for bad debts in the banking and lending segment.
The 1996 provision for income taxes reflects reductions for the favorable
resolution of certain federal income tax contingencies and the recognition of
additional deferred tax benefits.
The number of shares used to calculate primary earnings (loss) per share amounts
was 61,001,000 and 60,569,000 for the six month periods ended June 30, 1997 and
1996, respectively, and 61,303,000 and 60,552,000 for the three month periods
ended June 30, 1997 and 1996, respectively. The number of shares used to
calculate fully diluted earnings (loss) per share amounts was 64,124,000 and
60,569,000 for the six month periods ended June 30, 1997 and 1996, respectively,
and 64,140,000 and 60,552,000 for the three month periods ended June 30, 1997
and 1996, respectively. For fully diluted per share amounts, the 5 1/4%
Debentures were not assumed to have been converted in 1996 since the effect of
such assumed conversion would have been to increase earnings per share. The
increase in the number of shares utilized in calculating per share amounts
principally related to the conversion of the 5 1/4% Debentures, as more fully
described above.
-12-
<PAGE>
PART II - OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS.
On May 11, 1994, a shareholder of the Company filed a
purported derivative action entitled Pinnacle Consultants,
Ltd. v. Leucadia National Corporation, et al. (C.A. No. 94
Civ. 3496) against the Company's current Board of Directors
and two former directors, John W. Jordan II and Melvin
Hirsch. The action, which was filed in the United States
District Court for the Southern District of New York, alleged
certain Racketeer Influence and Corrupt Organizations Act,
securities law, conversion and fraud claims that were
dismissed with prejudice by the Court and two state law
claims of waste and breach of fiduciary duty that were
dismissed by the Court for lack of jurisdiction. On December
10, 1996, the Second Circuit Court of Appeals affirmed the
order of the District Court dismissing plaintiff's complaint.
On May 13, 1997, Pinnacle filed a purported derivative
complaint in New York State Supreme Court. The action,
entitled Pinnacle Consultants, Ltd. v. Leucadia National
Corporation, et al. (No. 602470/97), is substantially similar
to the federal court complaint that was dismissed in 1996.
Pinnacle has alleged claims for fraud, waste, breach of
fiduciary duty and conversion against the same current and
former Leucadia directors who were named as defendants in the
federal court action. On August 1, 1997, defendants moved to
dismiss the complaint.
Item 6. EXHIBITS AND REPORTS ON FORM 8-K.
A) EXHIBITS.
10.1 Purchase Agreement among Conseco, Inc., Leucadia
National Corporation, Charter National Life Insurance
Company, Colonial Penn Group, Inc., Colonial Penn
Holdings Inc., Leucadia Financial Corporation,
Intramerica Life Insurance Company, Colonial Penn
Franklin Insurance Company and Colonial Penn
Insurance Company dated as of April 30, 1997.
10.2 Purchase Agreement among General Electric Capital
Corporation, Leucadia National Corporation, Charter
National Life Insurance Company, Colonial Penn
Group, Inc. and Colonial Penn Holdings Inc. dated as
of June 30, 1997 (filed as Annex A to the
Preliminary Proxy Statement for the Company's 1997
Annual Meeting of Shareholders).*
27 Financial Data Schedule.
B) REPORTS ON FORM 8-K.
The Company filed a current report on Form 8-K dated April 7,
1997 which sets forth information under Item 5. Other Events
and Item 7. Financial Statements, Pro Forma Financial
Statements and Exhibits.
The Company filed a current report on Form 8-K dated April
30, 1997 which sets forth information under Item 5. Other
Events and Item 7. Financial Statements, Pro Forma Financial
Statements and Exhibits.
The Company filed a current report on Form 8-K dated June 30,
1997 which sets forth information under Item 5. Other Events
and Item 7. Financial Statements, Pro Forma Financial
Statements and Exhibits.
- ----------------------------------
*Incorporated by reference
-13-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
LEUCADIA NATIONAL CORPORATION
(Registrant)
Date: August 13, 1997 By /s/ Barbara L. Lowenthal
---------------------------------------
Barbara L. Lowenthal
Vice President and Comptroller
(Chief Accounting Officer)
-14-
<PAGE>
EXHIBIT INDEX
Exhibit Exemption
Number Description Indication
------ ----------- ----------
10.1 Purchase Agreement among Conseco, Inc.,
Leucadia National Corporation, Charter
National Life Insurance Company, Colonial
Penn Group, Inc., Colonial Penn Holdings
Inc., Leucadia Financial Corporation,
Intramerica Life Insurance Company, Colonial
Penn Franklin Insurance Company and Colonial
Penn Insurance Company dated as of April 30,
1997.
10.2 Purchase Agreement among General Electric
Capital Corporation, Leucadia National
Corporation, Charter National Life Insurance
Company, Colonial Penn Group, Inc. and
Colonial Penn Holdings Inc. dated as of June
30, 1997 (filed as Annex A to the Preliminary
Proxy Statement for the Company's 1997 Annual
Meeting of Shareholders).*
27 Financial Data Schedule.
- -------------------------------------
* Incorporated by reference
-15-
================================================================================
PURCHASE AGREEMENT
DATED AS OF APRIL 30, 1997
Among
CONSECO, INC.,
LEUCADIA NATIONAL CORPORATION,
CHARTER NATIONAL LIFE INSURANCE COMPANY,
COLONIAL PENN GROUP, INC.,
COLONIAL PENN HOLDINGS INC.,
LEUCADIA FINANCIAL CORPORATION,
INTRAMERICA LIFE INSURANCE COMPANY,
COLONIAL PENN FRANKLIN INSURANCE COMPANY,
and
COLONIAL PENN INSURANCE COMPANY
with respect to all of the
outstanding capital stock of
PROVIDENTIAL LIFE INSURANCE COMPANY
and
COLONIAL PENN LIFE INSURANCE COMPANY
and
certain other assets
================================================================================
NYFS04...:\30\76830\0226\1980\AGR3317U.00L
<PAGE>
TABLE OF CONTENTS
Page
ARTICLE I
SALE OF SHARES AND CLOSING
1.1 Purchase and Sale of Shares.............................. 2
1.2 Purchase Price........................................... 2
1.3 Closing.................................................. 2
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE SELLERS
2.1 Organization, Standing and Corporate Power............... 4
2.2 Capital Structure........................................ 5
2.3 Authority; Noncontravention.............................. 5
2.4 Financial Statements..................................... 6
2.5 No Undisclosed Liabilities............................... 7
2.6 Absence of Certain Changes or Events..................... 7
2.7 Taxes.................................................... 9
2.8 Absence of Changes in Benefit Plans...................... 11
2.9 Benefit Plans............................................ 11
2.10 Compliance with Applicable Laws.......................... 13
2.11 Litigation............................................... 15
2.12 Assets and Properties.................................... 15
2.13 Contracts................................................ 16
2.14 Insurance................................................ 17
2.15 Brokers and Advisors..................................... 17
2.16 Intellectual Property.................................... 18
2.17 Insurance Issued by CPL and PLI.......................... 18
2.18 Actuarial Studies........................................ 19
2.19 Threats of Cancellation.................................. 19
2.20 Labor Matters............................................ 20
2.21 Person Authorized to Act................................. 20
2.22 Accuracy of Information.................................. 20
2.23 Investment Intent........................................ 20
2.24 Environmental Matters.................................... 21
2.25 Statutory Surplus; No Dividends.......................... 21
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
3.1 Organization, Good Standing and Corporate
Power.................................................... 21
(i)
<PAGE>
3.2 Authority; Noncontravention.............................. 22
3.3 SEC Documents............................................ 23
3.4 Absence of Certain Changes or Events..................... 23
3.5 Litigation............................................... 24
3.6 Brokers.................................................. 24
3.7 Purchase for Investment.................................. 24
3.8 No Regulatory Disqualifiers.............................. 24
3.9 Accuracy of Information.................................. 24
ARTICLE IV
ADDITIONAL AGREEMENTS
4.1 Access to Information; Confidentiality................... 25
4.2 Commercially Reasonable Efforts.......................... 25
4.3 Public Announcements..................................... 25
4.4 Consents, Approvals and Filings.......................... 26
4.5 Tax Matters.............................................. 26
4.6 Employee Benefit Matters................................. 31
4.7 Reinsurance of Certain Health Insurance
Policies................................................. 32
4.8 Intramerica Reinsurance.................................. 32
4.9 Intercompany Agreements.................................. 33
4.10 Limited License; Trademark Ownership and
Protection: Change of Name............................... 35
4.11 Standby L/C.............................................. 36
4.12 Hiring of Employees...................................... 36
4.13 Marketing Database....................................... 36
4.14 Leucadia Stock Options................................... 36
4.15 Resignations of Directors................................ 36
ARTICLE V
COVENANTS RELATING TO CONDUCT OF BUSINESS PRIOR TO CLOSING
5.1 Conduct of Business by the Companies..................... 37
5.2 Other Actions............................................ 39
ARTICLE VI
CONDITIONS PRECEDENT
6.1 Conditions to Each Party's Obligation To
Consummate Transactions.................................. 40
6.2 Conditions to Obligations of the Purchaser............... 40
6.3 Conditions to Obligations of the Sellers................. 41
(ii)
<PAGE>
ARTICLE VII
TERMINATION, AMENDMENT AND WAIVER
7.1 Termination.............................................. 42
7.2 Effect of Termination.................................... 42
ARTICLE VIII
SURVIVAL OF PROVISIONS
8.1 Survival................................................. 42
ARTICLE IX
INDEMNIFICATION
9.1 Indemnification by Sellers............................... 43
9.2 Indemnification by the Purchaser......................... 43
9.3 Limitations on Indemnification........................... 43
9.4 Notice of Defense of Claims.............................. 45
ARTICLE X
NOTICES
10.1 Notices.................................................. 46
ARTICLE XI
MISCELLANEOUS
11.1 Entire Agreement......................................... 47
11.2 Expenses................................................. 48
11.3 Counterparts............................................. 48
11.4 No Third Party Beneficiary............................... 48
11.5 Governing Law............................................ 48
11.6 Amendments and Supplements............................... 48
11.7 Assignment; Binding Effect............................... 48
11.8 Enforcement.............................................. 49
11.9 Headings, Gender, etc.................................... 49
11.10 Invalid Provisions....................................... 50
11.11 Revisions to Certain Exhibits............................ 50
(iii)
<PAGE>
PURCHASE AGREEMENT
THIS PURCHASE AGREEMENT (this "Agreement") is made and entered into this
30th day of April, 1997 by and among Conseco, Inc., an Indiana corporation (the
"Purchaser"), Leucadia National Corporation, a New York corporation
("Leucadia"), Charter National Life Insurance Company, a Missouri corporation
and wholly-owned subsidiary of Leucadia ("Charter"), Colonial Penn Group, Inc.,
a Delaware corporation and wholly-owned subsidiary of Charter ("CPG"), Colonial
Penn Holdings Inc., a Delaware corporation and wholly-owned subsidiary of CPG
("CP Holdings", together with Leucadia, Charter and CPG, the "Sellers"),
Leucadia Financial Corporation, a Utah corporation ("Leucadia Financial"),
Intramerica Life Insurance Company, a New York corporation ("Intramerica"),
Colonial Penn Franklin Insurance Company, a Pennsylvania corporation ("CPF"),
and Colonial Penn Insurance Company, a Pennsylvania corporation ("CPI").
WHEREAS, Leucadia owns all of the issued and outstanding shares of the
common stock, par value $100 per share ("PLI Common Stock"), of Providential
Life Insurance Company, an Arkansas corporation ("PLI") and CP Holdings owns all
of the issued and outstanding shares of common stock, par value $10 per share
("CPL Common Stock"), of Colonial Penn Life Insurance Company, a Pennsylvania
corporation ("CPL", and together with CPL's subsidiary, CP Real Estate Services
Corp. ("CP Real Estate"), and PLI and PLI's subsidiaries, U.S. Insurance
Marketing, Inc. ("U.S. Insurance") and Eagle Mortgage Company ("Eagle"), the
"Companies"); and
WHEREAS, Leucadia desires to sell all of the issued and outstanding shares
of PLI Common Stock and CP Holdings desires to sell all of the issued and
outstanding shares of CPL Common Stock to the Purchaser, and the Purchaser
desires to purchase all of the issued and outstanding shares of PLI Common Stock
and CPL Common Stock from Leucadia and CP Holdings, respectively, on the terms
and subject to the conditions set forth in this Agreement;
WHEREAS, in connection with the sale of the shares of PLI Common Stock and
the shares of CPL Common Stock, the Sellers, Leucadia Financial, Intramerica,
CPF, CPI and the Purchaser desire to consummate certain reinsurance
transactions, certain contract assignments, and certain other transactions on
the terms and conditions set forth in this Agreement.
1
<PAGE>
NOW, THEREFORE, in consideration of the mutual covenants and agreements
set forth in this Agreement, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereby
agree as follows:
ARTICLE I
SALE OF SHARES AND CLOSING
1.1 Purchase and Sale of Shares. Subject to the terms and conditions, and
in reliance upon the representations and warranties, set forth in this
Agreement, Leucadia agrees, and Leucadia, Charter and CPG agree to cause CP
Holdings to agree, to sell all of the issued and outstanding shares of PLI
Common Stock and CPL Common Stock, respectively, to the Purchaser, and the
Purchaser agrees to purchase all of the issued and outstanding PLI Common Stock
and CPL Common Stock from Leucadia and CP Holdings, respectively.
1.2 Purchase Price. The consideration for (i) the shares of PLI Common
Stock, (ii) the shares of CPL Common Stock, (iii) the reinsurance transactions
described in Sections 4.7 and 4.8 and (iv) the contract assignments described in
Section 4.9(b) will equal $460,000,000 (the "Purchase Price"). The Purchase
Price shall be allocated and payable in the manner and form set forth on Annex A
hereto.
1.3 Closing.
(a) Unless this Agreement shall have been terminated and the transactions
contemplated hereby shall have been abandoned pursuant to Section 7.1, and
subject to the satisfaction and waiver of the conditions set forth in Article
VI, the closing of the transactions contemplated hereby (the "Closing") shall
take place at 10:00 a.m., New York time, on the second business day after
satisfaction of the conditions set forth in Section 6.1 (the "Closing Date"), at
the offices of Weil, Gotshal & Manges LLP, 767 Fifth Avenue, New York, New York
10153, unless another date, time or place is agreed to in writing by the
Purchaser and the Sellers.
(b) At the Closing, in accordance with Annex A hereto, the Purchaser (i)
shall pay $12,000,000 of the Purchase Price to Leucadia by wire transfer of
immediately available funds to such account as Leucadia specifies to the
Purchaser; (ii) shall pay $400,000,000 of the Purchase Price to CP Holdings by
executing and delivering to CP Holdings eight (8) promissory notes, each of
which shall be in a principal amount of $50 million and all of which together
shall be in an aggregate principal amount equal to $400,000,000, each of which
promissory notes shall be in the form
2
<PAGE>
of Exhibit A attached hereto (each a "Purchaser Note") and each of which shall
be fully supported at all times prior to the irrevocable payment in full of such
Purchaser Note by a non-transferable (except together with such Purchaser Note),
irrevocable standby letter of credit (which may be drawn upon in accordance with
the terms thereof) substantially in the form of Exhibit B attached hereto issued
for the benefit of CP Holdings by at least eight (8) commercial banks, each of
which is acceptable to Leucadia (a "Qualified Bank") such standby letter of
credit being referred to as a "Standby L/C"); (iii) shall pay, or cause to be
paid, $20,000,000 of the Purchase Price to Leucadia Financial by wire transfer
of immediately available funds to such account as Leucadia specifies to the
Purchaser; (iv) shall pay $3,000,000 of the Purchase Price to CPF (or, to
Leucadia or a subsidiary of Leucadia as Purchaser shall be directed by Leucadia
if Leucadia shall have sold CPF prior to the Closing) by wire transfer of
immediately available funds to such account as Leucadia specifies to the
Purchaser; (v) shall pay $25,000,000 of the Purchase Price to Intramerica by
wire transfer of immediately available funds to such account as Leucadia
specifies to the Purchaser; and (vi) shall execute and deliver to Leucadia (for
Leucadia and, as applicable, Leucadia Financial, CP Holdings and Intramerica),
Leucadia Financial, CP Holdings and Intramerica such documents and instruments
required to be executed and delivered by the Purchaser under the terms of this
Agreement. Purchaser may, at its election, substitute for the eight Standby
L/Cs, one master standby letter of credit (the "Master Standby L/C"), which
Master Standby L/C shall fully support each Purchaser Note. The Master Standby
L/C shall be issued by at least eight Qualified Banks which shall participate
therein in accordance with their respective commitments. The participation of
each Qualified Bank shall be for no more than one-eighth of the aggregate amount
specified to be supported by all of the Standby L/Cs. The Master Standby L/C
shall be in such form as shall in substance provide to CP Holdings equivalent
rights as CP Holdings would have received had Purchaser not made this election.
If Purchaser elects to deliver the Master Standby L/C in accordance with the
terms hereof, all references to any Standby L/C's in this Agreement shall be
deemed to refer to such Master Standby L/C.
(c) At the Closing, Leucadia shall execute and deliver, or cause to be
executed and delivered, to the Purchaser (for the Purchaser and, as applicable,
the Purchaser's NY Affiliate) (A) a certificate or certificates representing all
of the issued and outstanding shares of PLI Common Stock, accompanied by duly
executed stock powers, (B) a certificate or certificates representing all the
issued and outstanding shares of CPL Common Stock, accompanied by duly executed
stock powers, and (C) such documents and instruments required to be executed and
delivered by any of the Sellers or Leucadia Financial, Intramerica, CPF or
3
<PAGE>
CPI under the terms of this Agreement including the NY Reinsurance Treaty (as
defined in Section 4.8(a)) and the Non-NY Reinsurance Treaty (as defined in
Section 4.8(b)).
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE SELLERS
Each of the Sellers hereby represents and warrants to the Purchaser as
follows:
2.1 Organization, Standing and Corporate Power. Each of the Sellers and
the Companies is a corporation duly organized, validly existing, and in good
standing under the laws of the jurisdiction set forth opposite such entity's
name in Section 2.1 of the disclosure schedule dated the date hereof and
delivered concurrently herewith by the Sellers to the Purchaser (the "Seller
Disclosure Schedule") and has the requisite corporate power and authority to
carry on its business as now being conducted. Each of the Sellers and the
Companies is duly qualified or licensed to do business and is in good standing
in each jurisdiction in which the nature of its business or the ownership or
leasing of its assets makes such qualification or licensing necessary, except
where the failure to be so qualified or licensed and in good standing does not
have a material adverse effect on (i) the business, financial condition or
results of operations of the Companies, taken as a whole (a "Company Material
Adverse Effect"), (ii) the legal ability of Sellers to consummate the
transactions contemplated by this Agreement or (iii) the validity or
enforceability of this Agreement. For purposes of this definition, in
determining whether a Company Material Adverse Effect has occurred, the
insurance business of each of CPI, CPF and Intramerica being reinsured pursuant
to the reinsurance agreements required under Article IV hereof (the "Reinsured
Businesses") shall be treated as if such Reinsured Businesses had been conducted
by the Companies taken as a whole at the date of this Agreement. For avoidance
of doubt, it is the intention of the parties hereto that the Reinsured
Businesses are part of the business being sold to Purchaser and shall be treated
as if such had been added to the business, financial condition or results of
operations of the Companies taken as a whole. The Sellers have delivered to the
Purchaser complete and correct copies of the articles or certificate of
incorporation and bylaws of each of the Sellers and the Companies, as amended
through the date hereof.
4
<PAGE>
2.2 Capital Structure.
(a) Section 2.2 of the Seller Disclosure Schedule contains a true
and complete list of the authorized, issued, and outstanding capital stock of
each of the Companies.
(b) All issued and outstanding shares of capital stock of PLI and of
its two subsidiaries are duly authorized, validly issued, fully paid,
nonassessable and not subject to preemptive rights, and are owned beneficially
and (with respect to PLI only) of record by Leucadia, free and clear of any
lien, security interest, mortgage, charge, pledge, claim or encumbrance of any
kind or nature whatsoever (a "Lien") other than those Liens disclosed in Section
2.2 of the Seller Disclosure Schedule. All issued and outstanding shares of
capital stock of CPL are duly authorized, validly issued, fully paid,
non-assessable and not subject to preemptive rights, and are owned beneficially
and of record by CP Holdings, free and clear of any Lien.
(c) No bonds, debentures, notes or other indebtedness of any of the
Companies having the right to vote (or convertible into, or exchangeable for,
securities having the right to vote) on any matters on which the stockholders of
such Company may vote are issued or outstanding. None of the Companies has any
outstanding option, warrant, subscription or other right, agreement or
commitment which either (i) obligates such Company to issue, sell or transfer,
repurchase, redeem or otherwise acquire or vote any shares of the capital stock
of such Company or (ii) restricts the transfer of the PLI Common Stock or CPL
Common Stock.
(d) PLI owns 100% of the outstanding capital stock of U.S. Insurance
and Eagle, and CPL owns 100% of the outstanding capital stock of CP Real Estate
all of which is owned free and clear of any Lien.
2.3 Authority; Noncontravention. Each of the Sellers has the requisite
corporate power and authority to enter into this Agreement and to consummate the
transactions contemplated by this Agreement. The execution and delivery of this
Agreement by each Seller and the consummation by each Seller of the transactions
contemplated by this Agreement have been duly authorized by all necessary
corporate action on the part of such Seller. This Agreement has been duly
executed and delivered by each Seller and, assuming that this Agreement
constitutes a valid and binding agreement of the Purchaser, constitutes a valid
and binding obligation of each Seller, enforceable against each Seller in
accordance with its terms, except to the extent that the enforcement hereof may
be limited by (i) bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance or other
5
<PAGE>
similar laws now or hereafter in effect relating to creditors' rights generally
and (ii) general principles of equity (regardless of whether enforceability is
considered in a proceeding at Law (as hereinafter defined) or in equity). Except
as disclosed in Section 2.3 of the Seller Disclosure Schedule, the execution and
delivery of this Agreement by the Sellers do not, and the consummation by the
Sellers of the transactions contemplated by this Agreement and compliance with
the provisions of this Agreement will not (i) conflict with any of the
provisions of the articles or certificate of incorporation or by-laws of any
Seller or Company, (ii) subject to the governmental filings and other matters
referred to in the following sentence, conflict with, result in a breach of or a
default (with or without notice or lapse of time, or both) under, or give rise
to a right of termination, cancellation or acceleration of any obligation or
loss of a material benefit under, or require the consent of any person under,
any indenture, or other agreement, permit, concession, franchise, license or
similar instrument or undertaking to which any Seller or Company is a party or
by which any Seller or Company or any material portion of its assets is bound,
or (iii) subject to the governmental filings and other matters referred to in
the following sentence, contravene any law, statute, ordinance, or regulation of
the United States of America or any state, commonwealth, city, county,
municipality or other political subdivision thereof (collectively, "Law") or any
order, writ, judgment, injunction, decree, determination or award currently in
effect. No consent, approval or authorization of, or declaration or filing with,
or notice to, any governmental agency, department, commission, board, bureau,
regulatory authority or instrumentality ("Governmental Entity") which has not
been received or made is required by or with respect to any Seller or Company in
connection with the execution and delivery of this Agreement by the Sellers or
the consummation by the Sellers of any of the transactions contemplated by this
Agreement, except for (i) the filing of premerger notification and report forms
under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and
the rules and regulations promulgated thereunder (the "HSR Act"), (ii) the
consents, filings and/or notices required under the insurance laws of the
jurisdictions set forth in Section 2.3 of the Seller Disclosure Schedule, and
(iii) such other consents, approvals, authorizations, filings or notices of
which the failure to obtain would not, individually or in the aggregate, have a
Company Material Adverse Effect.
2.4 Financial Statements.
(a) The Sellers have previously delivered to the Purchaser true and
complete copies of the Annual Statement (including without limitation the Annual
Statements of any separate accounts) for the years ended December 31, 1996 and
1995,
6
<PAGE>
together with all exhibits and schedules thereto, and any actuarial opinion,
affirmation or certification filed in connection therewith, of each of CPL and
PLI (each a "Company Annual Statement"), as filed with the insurance regulatory
authority in the state in which such Company is domiciled (an "Insurance
Regulator"). Each such Company Annual Statement was prepared in conformity with
the NAIC annual statement instructions and the accounting practices and
procedures manuals ("SAP"), presents fairly, in all material respects, to the
extent required by and in conformity with SAP, the statutory assets, and
statutory liabilities, surplus and other funds, of such Company at the date
thereof and the summary of operations, changes in capital and surplus and cash
flow of such Company for the period then ended, and was correct in all material
respects when filed and there were no material omissions therefrom when filed.
No deficiencies or violations have been asserted in writing by any Insurance
Regulator which have not been cured or otherwise resolved to the satisfaction of
such Insurance Regulator and which have not been disclosed in writing to
Purchaser prior to the date of this Agreement, other than those which would not
have a Company Material Adverse Effect.
(b) The Sellers have previously delivered to the Purchaser true and
complete copies of the unaudited trial balances of CP Real Estate as at December
31, 1995 and 1996 (the "CP Real Estate Financials"). The foregoing CP Real
Estate Financials are true and complete in all material respects and fairly
presents the financial position of CP Real Estate.
2.5 No Undisclosed Liabilities. Except as disclosed in Section 2.5 of the
Seller Disclosure Schedule, there is no liability against, relating to, or
affecting any of the Companies that is of the type required to be disclosed on a
balance sheet prepared in accordance with SAP (or generally accepted accounting
principles with respect to CP Real Estate), except (i) liabilities disclosed in
such Company's Company Annual Statement or the CP Real Estate Financials, (ii)
policyholder benefits payable, or other liabilities incurred since December 31,
1996, in the ordinary course of business, consistent with past practice and
(iii) liabilities that would not have a Company Material Adverse Effect.
2.6 Absence of Certain Changes or Events. Except as disclosed in Section
2.6 of the Seller Disclosure Schedule or as contemplated or otherwise permitted
by this Agreement and except for changes resulting from events, conditions, or
effects of an industry-wide or national scope, since December 31, 1996, each of
the Companies has conducted its business only in the ordinary course and there
has not been (i) any change which would have a Company Material Adverse Effect;
(ii) any declaration, setting aside or payment of any dividend or other
distribution (whether
7
<PAGE>
in cash, stock or property) with respect to the PLI Common Stock or the CPL
Common Stock; (iii) any split, combination or reclassification of any of the PLI
Common Stock or the CPL Common Stock, any issuance or the authorization of any
issuance of any other securities in respect of, in lieu of or in substitution
for shares of the PLI Common Stock or the CPL Common Stock or any direct or
indirect redemption, purchase or other acquisition by the Companies of any such
stock or of any interest in or right to acquire any such stock; (iv) (A) any
granting by any of the Companies to any officer of such Company of any increase
in compensation, (B) any granting by any of the Companies to any such officer of
any increase in severance or termination pay, or (C) any entry by any of the
Companies into any employment, severance or termination agreement with any such
officer, (v) any change in accounting methods, principles or practices by any of
the Companies affecting its assets, liabilities or business, except insofar as
such change may have been required by a change in SAP and would not have a
Company Material Adverse Effect; (vi) any Lien created on or in any of the
assets and properties of any Company, or assumed by any Company with respect to
any of such assets and properties, which Lien relates to liabilities
individually or in the aggregate exceeding $50,000 for all such companies; (vii)
any prepayment of any liabilities individually or in the aggregate exceeding
$50,000; (viii) any liability involving the borrowing of money by any of the
Companies in an amount in excess of $50,000; (ix) any liability incurred by any
of the Companies in any transaction (other than pursuant to any insurance or
annuity Contract) not involving the borrowing of money, in an amount in excess
of $50,000 except in the ordinary course of business and consistent with past
practices for such companies; (x) any damage, destruction, or other casualty
(whether or not covered by insurance) affecting any of the assets and properties
of any of the Companies which damage, destruction, or loss individually exceeds
$250,000 or the result of which individually exceeds $250,000; (xi) any work
stoppage, strike, labor difficulty, or (to the best knowledge of Sellers) union
organizational campaign (in process or threatened) at or affecting any of the
Companies; (xii) any material payment, discharge, or satisfaction by any of the
Companies of any Lien or liability other than Liens or liabilities that (i) were
paid, discharged, or satisfied since December 31, 1996 in the ordinary course of
business and consistent with past practice, or (ii) were paid, discharged or
satisfied as required under this Agreement; (xiii) any cancellation of any
liability in excess of an aggregate of $50,000 owed to any of the Companies by
any other Person; (xiv) any write-off or write-down of, or any determination to
write off or down any of, the assets and properties of any of the Companies or
any portion thereof, except for write-offs or write-downs that do not exceed
$50,000 individually or $100,000 in the aggregate for all such Companies; (xv)
except for securities held for investment, any sale,
8
<PAGE>
transfer, or conveyance of any assets and properties, of any of the Companies
with an individual book value or with an aggregate book value in excess of
$50,000, except as contemplated in this Agreement, and except in the ordinary
course of business and consistent with past practice for each such Company;
(xvi) any amendment, termination, waiver, disposal, or lapse of, or other
failure to preserve, any license or other form of authorization of any of the
Companies (except as indicated on Section 2.6 of the Seller Disclosure
Schedule), which is material to the conduct of the business of the Companies,
taken as a whole; (xvii) any material loan or material advance to any Seller,
any affiliate of the Companies, Seller or any of the directors, officers,
employees, consultants, agents or other representatives of any Sellers or any
Company; (xviii) any material amendment of, or any failure to perform all of its
material obligations under, or any material default under, or any waiver of any
material right under, or any termination (other than on the stated expiration
date) of any contract that involves or reasonably would involve the annual
expenditure or receipt by any of the Companies of more than $50,000; (xix) any
amendment to the articles or certificate of incorporation or by-laws of any of
the Companies; (xx) any termination (other than on the stated expiration date),
amendment, or execution by any of the Companies of any material reinsurance,
material coinsurance, or other similar material contract, as ceding or assuming
insurer; (xxi) any expenditure or commitment for additions to property, plant,
equipment or other tangible or intangible capital assets of any of the
Companies, except for any expenditure or commitment that does not exceed $50,000
individually or $100,000 in the aggregate; (xxii) any material modification in
any material compensation contract entered into with insurance agents; (xxiii)
any material increase in the promotional expenses undertaken with respect to
direct response lines of insurance offered by any of the Companies; or (xxiv)
any contract to take any of the actions described in this Section 2.6 other than
actions expressly permitted under this Section 2.6.
2.7 Taxes.
(a) Except as disclosed in Section 2.7 of the Seller Disclosure Schedule,
each of the Companies has filed all Tax Returns (as hereinafter defined)
required to be filed by it on or prior to the date hereof or requests for
extensions to file such Tax Returns have been timely filed, granted and have not
expired except to the extent that such failures to file or to have extensions
granted that remain in effect, individually and in the aggregate, would not have
a Company Material Adverse Effect. All Tax Returns filed by any of the Companies
are complete and accurate except to the extent that such failure to be complete
and accurate would not have a Company Material Adverse Effect. Each of the
Companies has paid (or has had paid on its behalf)
9
<PAGE>
all Taxes (as hereinafter defined) shown due on such Company's returns, and
liabilities and reserves for Taxes reflected on the Company Annual Statements
and the CP Real Estate Financials are adequate in all material respects for
Taxes payable by the Companies for all taxable periods and portions thereof
accrued through December 31, 1996.
(b) Except as set forth on Section 2.7 of the Seller Disclosure Schedule,
no deficiencies for any Taxes (as hereinafter defined) have been proposed,
asserted or assessed in writing against any of the Companies that are not
adequately reserved for in accordance with SAP or GAAP, as appropriate, except
for deficiencies that, individually or in the aggregate, would not have a
Company Material Adverse Effect, and no written requests for waivers of the time
to assess any such Taxes have been granted or are pending. Except as disclosed
in Section 2.7 of the Seller Disclosure Schedule, the material Tax Returns of
the Companies for all years prior to 1993 have been examined by and settled with
the applicable Governmental Entity, or the statute of limitations on assessment
or collection of Taxes due in respect of such Tax Returns from the Companies has
expired.
(c) As used in this Agreement, "Taxes" shall include all United States
federal, state,local and foreign income, property, premium, sales, excise,
employment, payroll, withholding and other taxes, tariffs or governmental
charges of any nature whatsoever and any interest, penalties and additions to
taxes relating thereto. As used in this Agreement, "Tax Returns" shall include
any return, report, information return, or other document (including any related
or supporting information) filed or required to be filed with any Governmental
Entity in connection with the determination, assessment, collection, or
administration of any taxes.
(d) Neither PLI nor CPL have agreed, been requested to, has an application
pending or is required to make any adjustment under Section 481(a) of the Code.
(e) No intercompany tax payment made by PLI or CPL to the Seller or any
affiliate of the Seller will be for any amounts relating to years prior to 1997.
(f) The Company has no contracts outstanding which fail to qualify as life
insurance under the provisions of Section 7702 of the Code on which material
accumulated income has not been reported to policyholders, except such failure
which does not create a Company Material Adverse Effect. There are no contracts
outstanding which are modified endowment contracts as defined in Section 7702A
of the Code with respect to which the Companies' material reporting obligations
have not been satisfied, except
10
<PAGE>
such failure to satisfy which does not create a Company Material Adverse Effect.
2.8 Absence of Changes in Benefit Plans. Except as disclosed in Section
2.8 of the Seller Disclosure Schedule, since December 31, 1996, there has not
been any adoption or amendment by any of the Companies of any collective
bargaining agreement or any Benefit Plan (as defined in Section 2.9). Except as
disclosed in Section 2.8 of the Seller Disclosure Schedule, there exist no
written employment, consulting, severance, termination or indemnification
agreements, arrangements or understandings between any of the Companies and any
current or former employee, officer or director of any such Company.
2.9 Benefit Plans.
(a) None of the Companies maintains, administers or contributes to: (1)
any employee benefit plan (as defined in Section 3(3) of the Employee Retirement
Income Security Act of 1974, as amended ("ERISA") ("Plan")), including, without
limitation, any multiemployer plan as defined in Section 3(37) of ERISA
("Multiemployer Plan") or (2) any bonus, deferred compensation, performance
compensation, stock purchase, stock option, stock appreciation, severance,
salary continuation, vacation, sick leave, holiday pay, fringe benefit,
personnel policy, reimbursement program, incentive, insurance, welfare or
similar plan, program, policy or arrangement ("Benefit Plan"), other than those
Plans and Benefit Plans described in Section 2.9 of the Seller Disclosure
Schedule. All Plans and Benefit Plans and all related trust agreements or
annuity contracts (or related trust instruments) comply in all material respects
with and are and have been operated in all material respects in accordance with
ERISA, the Code, other Federal statutes, state law and the regulations and rules
promulgated pursuant thereto or in connection therewith. Except as described in
Section 2.9 of the Seller Disclosure Schedule, no withdrawals have occurred so
as to cause any Plan to become subject to the provisions of Section 4063 of
ERISA, nor have any of the Companies ceased making contributions to any Plan
subject to Section 4064(a) of ERISA to which any of the Companies made
contributions during the six (6) years prior to the date hereof nor ceased
operations at a facility so as to become subject to Section 4062(e) of ERISA.
True and complete copies of each Plan, Benefit Plan, related trust agreements,
annuity contracts, determination letters, summary plan descriptions, annual
reports on Form 5500 and Form 990, if any, will be made available to Purchaser.
None of the Companies has incurred any liability to the Pension Benefit Guaranty
Corporation ("PBGC"), including as a result of the voluntary or involuntary
termination of any Plan which is subject to Title IV of ERISA. There is
currently no active filing by any of the Companies with the PBGC (and no
proceeding has been
11
<PAGE>
commenced by the PBGC and no condition exists and no event has occurred that
could constitute grounds for the termination of any Plan by the PBGC) to
terminate any Plan which is subject to Title IV of ERISA and which has been
maintained or funded, in whole or in party, by any of the Companies. None of the
Companies has ever contributed to or been obligated to contribute to a
Multiemployer Plan.
(b) Except as disclosed in Section 2.9 of the Seller Disclosure Schedule,
there has been no reportable event, as defined in Section 4043(b) of ERISA, nor
has there been any event which would require a report to the PBGC, Department of
Labor or Internal Revenue Service under ERISA or the Code (other than summary
plan descriptions and annual reports filed in the normal course), with respect
to any Plan or any Benefit Plan for which notice has not been waived by rule or
regulation. Except as disclosed in Section 2.9 of the Seller Disclosure
Schedule, none of the Companies has any liability to the PBGC (other than any
liability for insurance premiums not yet due to the PBGC), to any present or
former participant in or beneficiary of any Plan or Benefit Plan, or any
beneficiary of any such participant or beneficiary (except with respect to
normal benefits due under any Plan or Benefit Plan), or to any Plan or Benefit
Plan (except with respect to normal funding obligations). Except as disclosed in
Section 2.9 of the Seller Disclosure Schedule, no event, fact or circumstance
has arisen or occurred that has, subject only to the exceptions in the preceding
sentence, resulted in or may reasonably be expected to result in any such
liability or a claim against any of the Companies by the PBGC, by any present or
former participant in or any beneficiary of any Plan or Benefit Plan (or any
beneficiary of any such participant or beneficiary), or by any such Plan or
Benefit Plan. Except as disclosed in Section 2.9 of the Seller Disclosure
Schedule, (1) no filing has been or will be made by any of the Companies in
connection with the complete or partial termination of any Plan, (2) no complete
or partial termination of any Plan has occurred or, as a result of the execution
or delivery of this Agreement or the consummation of the transactions
contemplated by this Agreement, will occur, except as otherwise disclosed in
Section 2.9 of the Seller Disclosure Schedule, and (3) none of the Companies has
engaged in any transaction, within the meaning of Section 4069 of ERISA.
(c) The actuarial assumptions utilized, where appropriate, in connection
with determining the funding of each Plan which is a defined benefit pension
plan (as set forth in the actuarial report for such Plan) are reasonable. A copy
of the latest such actuarial report has been previously furnished to the
Purchaser. Based on such actuarial assumptions, as of December 31, 1996, the
fair market value of the assets or properties held under each such Plan exceeds
the actuarially determined present value of all
12
<PAGE>
accrued benefits of such Benefit Plan (whether or not vested) determined on an
ongoing Plan basis.
(d) Except as disclosed in Section 2.9 of the Seller Disclosure Schedule,
there are no pending or, to the knowledge of the Sellers, threatened actions,
suits, investigations or other proceedings by any present or former participant
or beneficiary under any Plan or Benefit Plan (or any beneficiary of any such
participant or beneficiary) involving any Plan or Benefit Plan or any rights or
benefits under any Plan or Benefit Plan other than ordinary and usual claims for
benefits by participants or beneficiaries thereunder. There is no writ,
judgment, decree, injunction or similar order of any court, governmental or
regulatory authority, or other similar Person outstanding against or in favor of
any Plan or Benefit Plan or any fiduciary thereof.
(e) Except as disclosed in Section 2.9 of the Seller Disclosure Schedule,
none of the Companies maintains or contributes to any Benefit Plan which
provides, or has any liability or obligation to provide, life insurance, medical
or other employee welfare benefits to any employee (or his beneficiary) upon
such employee's retirement or termination of employment except as may be
required by federal, state or local laws, rules or regulations, and none of the
Companies has ever represented, promised or contracted to or with any employee
or former employee that such employee or former employee would be provided life
insurance, medical or other employee welfare benefits upon their retirement or
termination of employment, except to the extent required by federal, state or
local laws, rules or regulations.
2.10 Compliance with Applicable Laws.
(a) Each of the Companies has in effect all federal, state, local and
foreign governmental approvals, authorizations, certificates, filings,
franchises, licenses, notices, permits and rights ("Permits") necessary for it
to own, lease or operate its assets and to carry on its business in all material
respects as now conducted, and, to the knowledge of the Sellers, there has
occurred no default under any such Permit, except where the failure to have such
Permits in effect or the default under such Permits would not, individually or
in the aggregate, have a Company Material Adverse Effect. Except as disclosed in
Section 2.10(a) of the Seller Disclosure Schedule, each of the Companies is in
compliance in all material respects with all applicable Laws, except where
non-compliance with such Laws would not, individually or in the aggregate, have
a Company Material Adverse Effect. Except as disclosed in Section 2.10(a) of the
Seller Disclosure Schedule and except for routine examinations by Insurance
Regulators, to the knowledge of the Sellers, no
13
<PAGE>
investigation by any Governmental Entity with respect to any of
the Companies is pending or threatened.
(b) Except as disclosed in Section 2.10(b) of the Seller Disclosure
Schedule, (i) each of the Companies (exclusive of its agents) and, to the
knowledge of the Sellers, its agents have marketed, sold and issued products of
such Company in compliance, in all material respects, with all Laws applicable
to the business of such Company in the respective jurisdictions in which such
products have been sold, except where the failure to do so, individually or in
the aggregate, has not had or would not reasonably be expected to have, a
Company Material Adverse Effect, (ii) there are (A) to the knowledge of the
Sellers, no claims asserted, (B) no actions, suits, investigations or
proceedings by or before any court or other Governmental Entity or (C) no
investigations by or on behalf of any Company ((A), (B) and (C) being
collectively referred to as "Actions") pending or, to the knowledge of the
Sellers, threatened, against or involving any of the Companies, or, to the
knowledge of the Sellers, any of its agents that include allegations that any of
the Companies or any of its agents were in violation of or failed to comply with
such Laws, and, to the knowledge of the Sellers, no facts exist which would
reasonably be expected to result in the filing or commencement of any such
Action, which Actions, individually or in the aggregate, would have a Company
Material Adverse Effect, and (iii) each of the Companies is in compliance, in
all material respects, with and has performed, in all material respects, all
obligations required to be performed by such Company under any cease-and-desist
or other order issued by any Insurance Regulator or other Governmental Entity to
such Company or under any written agreement, consent agreement, memorandum of
understanding or commitment letter or similar undertaking entered into between
any Insurance Regulator or other Governmental Entity and such Company (a
"Company Regulatory Agreement"), which Company Regulatory Agreement remains in
effect on the date hereof. Section 2.10(b) of the Seller Disclosure Schedule
lists all Company Regulatory Agreements, copies of which have previously been
provided to Purchaser.
(c) Section 2.10(b) of the Seller Disclosure Schedule lists the
jurisdictions in which each of CPL and PLI hold licenses (including, without
limitation, licenses or certificates of authority from applicable insurance
departments), permits, or authorizations to transact insurance or reinsurance
business (collectively, the "Insurance Licenses"). All such Insurance Licenses
are valid, binding, and in full force and effect. Each of CPL and PLI is duly
licensed in all jurisdictions in which it writes the lines of insurance offered
by it. No Insurance License is the subject of a proceeding for suspension or
revocation or any similar proceedings and, to the knowledge of
14
<PAGE>
the Sellers, there is no pending threat of such suspension or
revocation by any licensing authority.
(d) The Sellers have previously made available to the Purchaser, to the
extent applicable, true and complete copies of the reports reflecting the
results of the most recent financial examinations and market conduct examination
of the Companies issued by any Insurance Regulator.
2.11 Litigation. Except as disclosed in Section 2.11 of the Seller
Disclosure Schedule, (i) there is no action, suit, investigation or proceeding
pending, or, to the knowledge of the Sellers, threatened, against any Seller or
Company, at Law or in equity, in, before, or by any person or entity that has
had or would be reasonably expected to have (A) a material adverse effect on the
validity or enforceability of this Agreement or on the ability of such Seller to
perform its obligations under this Agreement or (B) a Company Material Adverse
Effect and (ii) there are no judgments, orders or decrees of any Governmental
Entity binding on any Seller or Company or any material portion of its
properties and assets.
2.12 Assets and Properties.
(a) Each of the Companies has good and marketable title to all debentures,
notes, stocks, securities, and other Assets that are of a type required to be
disclosed in Schedules B through DB of its Company Annual Statement and that are
owned by it, free and clear of all Liens, except (i) for Permitted Liens and
(ii) as disclosed in Section 2.12(a) of the Seller Disclosure Schedule. For
purposes hereof, "Permitted Lien" shall mean any (i) mechanic's, carrier's,
workmen's, repairmen's, or other similar Lien arising or incurred in the
ordinary course of business, (ii) Lien for taxes, assessments, and other
governmental charges that are not due and payable or that may hereafter be paid
without penalty or that are being contested in good faith, (iii) Lien on assets
in a Company's investment portfolio that arise or have been incurred in the
ordinary course of such Company's investing activities, and (iv) other Liens
that do not have a Company Material Adverse Effect.
(b) Section 2.12(b) of the Seller Disclosure Schedule contains a true and
complete list and description of all real property owned by any of the Companies
or included on Schedule A of either CPL's or PLI's Company Annual Statement. The
applicable Company has good and marketable fee title to such real property, free
and clear of all Liens, except (i) for Permitted Liens and (ii) as disclosed in
Section 2.12(b) of the Seller Disclosure Schedule.
15
<PAGE>
(c) Section 2.12(c) of the Seller Disclosure Schedule contains a true and
complete list and description of all real property leased by any of the
Companies that is material to the conduct of the business, operations, or
affairs of the Companies taken as a whole. The Sellers shall have made available
to the Purchaser true and complete copies of each lease or sublease as amended
to the date of this Agreement. Each such lease or sublease is in full force and
effect and none of the Companies is in default thereunder or has received any
notice of any default thereunder of any other party thereto, except in each case
where any such unenforceability, ineffectiveness or default would not have a
Company Material Adverse Effect.
(d) Except as disclosed in Section 2.12(d) of the Seller Disclosure
Schedule, the applicable Company has good and marketable title to, or has a
valid leasehold interest in or a valid right to use, all tangible personal
property that is material to the conduct of the business, operations, or affairs
of the Companies taken as a whole.
2.13 Contracts. (a) Section 2.13(a) of the Seller Disclosure Schedule
contains a true and complete list of each contract (excluding insurance/annuity
contracts) that (i) is between any of the Companies and any of the Sellers or
any of their affiliates, (ii) is necessary or material to the business,
operation, or affairs of the Companies, taken as a whole, or (iii) involves
payments in excess of $50,000 in any one fiscal year or $100,000 in the
aggregate in any five year period (unless such contract is terminable on not
more than one year's notice (a "Material Contract"), true and complete copies of
which have been made available to the Purchaser.
(b) Except as listed in Section 2.13(b) of the Seller Disclosure Schedule,
to the best of Sellers knowledge, none of the Companies is presently a party to
any:
(i) agreement for the sale or lease of any of the
assets and properties of the Companies other than
in the ordinary course of business;
(ii) material mortgage, pledge, conditional sales contract,
security agreement, factoring agreement, or other
similar material agreement with respect to any real or
personal property of any Company;
(iii) agreement with a labor union or labor association;
(iv) loan agreement, promissory note issued by it,
guarantee, subordination or similar type of
agreement involving any outstanding principal
amount of $100,000;
16
<PAGE>
(v) securities issued by any Company (other than
capital stock listed on Section 2.2 of the Seller
Disclosure Schedule);
(vi) noncompetition agreement; and
(vii) support agreement, guarantee or other agreement
for the benefit of any affiliate of any of the
Companies or Sellers.
(c) With respect to each Material Contract and each contract listed in
Section 2.13(b) of the Seller Disclosure Schedule (a "Section 2.13(b)
Contract"), (x) none of the Companies party thereto is, and to the knowledge of
the Sellers, no other party thereto is, in default in the performance,
observance or fulfillment of any obligation, covenant or condition contained
therein except where such defaults would not, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect and (y) to the
knowledge of Sellers, no event has occurred which with or without the giving of
notice or lapse of time, or both, would constitute a default thereunder except
where such defaults would not, individually or in the aggregate, reasonably be
expected to have a Company Material Adverse Effect. Except as disclosed in
Section 2.13 of the Seller Disclosure Schedule, no Material Contract or Section
2.13(b) Contract requires the consent of any party in connection with the
transactions contemplated hereby.
2.14 Insurance. Section 2.14 of the Seller Disclosure Schedule contains a
true and complete list of all material liability, property, workers
compensation, directors and officers liability, and other similar insurance
policies that insure the business, operations, or affairs of each of the
Companies or affect or relate to the ownership, use, or operations of any of its
assets. Excluding insurance policies that have expired and been replaced in the
ordinary course of business, no insurance policy has been cancelled within the
last year and, to the knowledge of the Sellers, no threat has been made to
cancel any insurance policy of any Company during such period. Except as
disclosed in Section 2.14 of the Seller Disclosure Schedule, all such insurance
will remain in full force and effect with respect to periods before the Closing.
No event has occurred, including, without limitation, the failure by any of the
Companies to give any notice or information or any of the Companies giving any
inaccurate or erroneous notice or information, which limits or impairs the
rights of such Company under any such insurance policies.
2.15 Brokers and Advisors. All negotiations relative to
this Agreement and the transactions contemplated hereby have been
17
<PAGE>
carried out by the Sellers directly with the Purchaser, without the intervention
of anyone on behalf of the Sellers in such manner as to give rise to any valid
claim by any person against the Purchaser or any of its subsidiaries for a
finder's fee, brokerage commission, transaction fee, investment banking fee, or
similar payment, except for Donaldson, Lufkin & Jenrette Securities Corporation
("DLJ"), whose fee will be paid by the Sellers and not the Companies. The
Sellers have retained Weil, Gotshal & Manges LLP as their legal advisors whose
fee will be paid by the Sellers and not the Companies.
2.16 Intellectual Property. Section 2.16 of the Seller Disclosure Schedule
contains a true and complete list and description of all marks, names,
trademarks, service marks, patents, patent rights, assumed names, logos, trade
secrets, copyrights, trade names, and service marks that are material to the
conduct of the business, operations, or affairs of the Companies. Except as set
forth in Section 2.16 of the Seller Disclosure Schedule, the Companies have, and
after the Closing will have, the right to use, free and clear of any Liens or
other encumbrances, such intellectual property and all computer software,
programs, and similar systems used by, owned by or licensed to the Companies and
material to the conduct of the business, operations, or affairs of the
Companies, including without limitation that certain License Agreement (No.
TCS-035- 1088), dated September 11, 1988, between International Business
Machines Corporation, Early, Cloud Solutions Unit and CPG and CPI, as amended
(the "Early Cloud Software"). To the knowledge of the Sellers, none of the
Companies is or, as a result of the transactions contemplated hereby will be, in
conflict with or in violation or infringement of, nor have the Sellers or the
Companies received any notice of any conflict with or violation or infringement
of or any claimed conflict with, any asserted rights of any other person with
respect to any such intellectual property or computer software, programs, or
similar systems.
2.17 Insurance Issued by CPL and PLI. Section 2.17 of the Seller
Disclosure Schedule is a true and complete list of, and Sellers have delivered
to Purchaser or made available true and complete copies of all contracts to
which either CPL or PLI is a party providing for reinsurance, coinsurance,
excess insurance, ceding of insurance, assumption of insurance or
indemnification of insurance liabilities. Except as required by Law or except as
disclosed in Section 2.17 of the Seller Disclosure Schedule:
(a) To the best of Seller's knowledge, all benefits arising under
any insurance or annuity contract payable by either CPL or PLI
and (to the best knowledge of Seller) by any other Person that
is a party to or bound by any reinsurance, coinsurance,
18
<PAGE>
or other similar contract with either CPL or PLI have in all
material respects been paid in accordance with the terms of
the contracts under which they arose, except for such benefits
for which either CPL or PLI reasonably believes there is a
reasonable basis to contest payment;
(b) No outstanding insurance or annuity contract issued,
reinsured, or underwritten by either CPL or PLI entitles the
holder thereof or any other person to receive a material
amount of dividends, distributions, or other benefits based on
the revenues or earnings of either CPL or PLI or any other
person;
(c) To the best of Sellers knowledge, both CPL and PLI maintain
policyholder records and values that are true and correct in
all material respects; and
(d) Sellers have previously delivered to Purchaser the
reports reflecting the results of the most recent
market conduct and financial examinations of each
of CPL and PLI issued by any insurance regulatory
authority. To the best knowledge of Seller, all
material deficiencies or violations in such
reports have been resolved to the satisfaction of
all applicable insurance regulatory authorities
and to the extent required by law, all insurance
policy forms currently utilized by either CPL or
PLI in connection with the issuance of new
policies have been approved in all material
respects by the applicable regulatory authority or
have been filed therewith and have not been
objected to with respect to the appropriateness of
the form employed by such authority within the
period provided for objection.
2.18 Actuarial Studies. Sellers have previously delivered to Purchaser
true and complete copies of all reports rendered by any consulting actuary (or
any other Person advising Sellers as to the adequacy of the claims reserves),
undertaken by Sellers, or any of the Companies with respect to the insurance
business conducted by any of such companies during the past two years for the
purpose of evaluating claims reserves.
2.19 Threats of Cancellation. Since December 31, 1995, no policyholder,
group of policyholder affiliates, or persons writing, selling, or producing
insurance business, that individually or in the aggregate accounted for 5% or
more of the premium or annuity income of either CPL or PLI with which such
policyholder or group was insured, or for which such Persons
19
<PAGE>
wrote, sold or produced insurance business, for the year ended December 31,
1996, has terminated or (to the best knowledge of Seller) threatened to
terminate its relationship with either CPL or PLI, as the case may be.
2.20 Labor Matters. Except as set forth in Section 2.20 of the Seller
Disclosure Schedule, the operation of the business of the Companies has not been
materially and adversely affected by labor problems. Sellers have no knowledge
of any facts which lead any of them to believe that such problems may in the
future have a Company Material Adverse Effect. To the best of Seller's
knowledge, except as set forth in Section 2.20 of the Seller Disclosure
Schedule, the activities of the Companies have been in compliance in all
material respects with all applicable laws respecting employment and employment
practices, terms and conditions of employment and wages and hours. Section 2.20
of the Seller Disclosure Schedule also sets forth, to the best of Sellers
knowledge, a description of all disputes or claims applicable to any Company,
pending or threatened, alleging employment discrimination, sexual harassment, or
any unfair practice.
2.21 Person Authorized to Act. Prior to Closing, Sellers shall deliver (a)
a true and complete list of the names and locations of all banks, trust
companies, Securities brokers, and other financial institutions at which each of
the Companies have an account or safe deposit box or maintains a banking,
custodial, trading, or other similar relationship, (b) a true and complete list
and description of each such account, box, and relationship, indicating in each
case the account number and the names of the respective officers, employees,
agents, or other similar representatives of the Companies transacting business
with respect thereto, (c) a true and complete list of each person authorized to
draw on each such account, entitled to have access thereto or authorized to
borrow money (or furnish security for the same) therefrom, and (d) a true and
complete list of each power of attorney granted to any person or persons for any
purpose.
2.22 Accuracy of Information. No representation or warranty by Sellers
contained in this Agreement contains, as of the date of execution of this
Agreement, or will contain at Closing Date, any untrue statement of a material
fact, or omits or will omit to state a material fact necessary to make the
statements contained herein and therein, in light of the circumstances under
which such statements are made, not misleading.
2.23 Investment Intent. The Purchaser Notes are being acquired by CP
Holdings for its own account, for investment only and CP Holdings has no present
intention of resale or other distribution thereof. CP Holdings acknowledges
that, in reliance
20
<PAGE>
on the foregoing representation, the Purchaser Notes have not been registered
under the Securities Act, as amended, or the securities act or Blue Sky laws of
any state. CP Holdings acknowledges that (a) Purchaser has disclosed to it that
such Purchaser Notes may not be resold absent such registration or unless an
exemption from registration is available and (b) such Purchaser Notes are
legended to such effect. CP Holdings has such knowledge and experience in
financial and business matters that it is capable of evaluating the merits and
risks of the purchase of such Purchaser Notes.
2.24 Environmental Matters. (a) to the best knowledge of Seller, the use
and operation by the Companies of real property owned, leased or used (the
"Facilities") have been, and on the Closing Date will be, in material compliance
with all environmental laws; and (b) no lien in favor of any governmental
authority for (i) any liability under environmental laws, or (ii) damages
arising from or costs incurred by such governmental authority in response to a
release of a contaminant into the environment has been filed or attached to the
Facilities.
2.25 Statutory Surplus; No Dividends. The statutory surplus (determined in
accordance with SAP) of CPL and PLI as at March 31, 1997 was not less than such
statutory surplus as at December 31, 1996, which was $66,859,850 and $4,784,392,
respectively. Since December 31, 1996, neither CPL nor PLI has paid any dividend
or made any other distribution in respect of its capital stock to any Seller or
any affiliates of the Sellers.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
The Purchaser hereby represents and warrants to the Sellers as follows:
3.1 Organization, Good Standing and Corporate Power. The Purchaser is a
corporation duly organized, validly existing, and in good standing under the
Laws of the jurisdiction in which it is incorporated and has the requisite
corporate power and authority to carry on its business as now being conducted.
The Purchaser is duly qualified or licensed to do business and is in good
standing in each jurisdiction in which the nature of its business or the
ownership or leasing of its assets makes such qualification or licensing
necessary, except where the failure to be so qualified or licensed does not have
a material adverse effect on (i) the business, financial condition or results of
operations of the Purchaser and its subsidiaries, taken as a whole (a "Purchaser
Material Adverse Effect"), (ii) the legal ability of the Purchaser to consummate
the transactions
21
<PAGE>
contemplated by this Agreement or (iii) the validity or enforceability of this
Agreement. The Purchaser has delivered to the Sellers complete and correct
copies of its articles or certificate of incorporation and by-laws, as amended
to the date of this Agreement.
3.2 Authority; Noncontravention. The Purchaser has all requisite corporate
power and authority to enter into this Agreement, to issue the Purchaser Note
and to consummate the other transactions contemplated by this Agreement. The
execution and delivery of this Agreement by the Purchaser, the issuance of the
Purchaser Note and the performance by the Purchaser of its other obligations
under this Agreement have been duly authorized by all necessary corporate action
on the part of the Purchaser. This Agreement has been duly executed and
delivered by the Purchaser and assuming that this Agreement constitutes a valid
and binding agreement of the Sellers, constitutes a legal, valid, and binding
obligation of the Purchaser and is enforceable against the Purchaser in
accordance with its terms, except to the extent that the enforcement hereof may
be limited by (i) any bankruptcy, insolvency, reorganization, moratorium, or
similar Laws now or hereafter in effect relating to or limiting creditors'
rights generally and (ii) general principles of equity (regardless of whether
enforceability is considered in a proceeding at Law or in equity). The execution
and delivery of this Agreement do not, and the issuance of the Purchaser Note
and the consummation of the other transactions contemplated by this Agreement
and compliance with the provisions of this Agreement will not (i) conflict with
any of the provisions of the articles or certificate of incorporation or by-laws
of the Purchaser, (ii) subject to the governmental filings and other matters
referred to in the following sentence, conflict with, result in a breach of or
default (with or without notice or lapse of time, or both) under, or give rise
to a right of termination, cancellation or acceleration of any obligation or
loss of a material benefit under, or require the consent of any person under,
any indenture, or other agreement, permit, concession, franchise, license or
similar instrument or undertaking to which the Purchaser is a party or by which
the Purchaser or any of its assets is bound, or (iii) subject to the
governmental filings and other matters referred to in the following sentence,
contravene any Law or any order, writ, judgment, injunction, decree,
determination or award currently in effect which, individually or in the
aggregate, would have a Purchaser Material Adverse Effect. No consent, approval
or authorization of, or declaration or filing with, or notice to, any
Governmental Entity which has not been received or made is required by or with
respect to the Purchaser in connection with the execution and delivery of this
Agreement by the Purchaser, the issuance of the Purchaser Note or the
consummation by the Purchaser of any of the transactions contemplated by this
Agreement, except for (i) the filing of
22
<PAGE>
premerger notification and report forms under the HSR Act, (ii) the filings
and/or notices required under the insurance laws of the jurisdictions set forth
in Section 2.3 of the Seller Disclosure Schedule, and (iii) such other consents,
approvals, authorizations, filings or notices of which the failure to obtain
would not, individually or in the aggregate, have a Purchaser Material Adverse
Effect.
3.3 SEC Documents. The Purchaser has filed all required reports,
schedules, forms, statements and other documents with the Securities and
Exchange Commission (the "SEC") since January 1, 1996 (such documents and the
exhibits thereto and documents incorporated therein by reference, together with
any other reports, schedules, forms, statements and other documents filed with
the SEC since January 1, 1996, are hereinafter referred to as the "Purchaser SEC
Documents"). As of their respective dates, the Purchaser SEC Documents complied
with the requirements of the Securities Act of 1933, as amended (the "Securities
Act") or the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
as the case may be, and the rules and regulations of the SEC promulgated
thereunder applicable to such Purchaser SEC Documents, and none of the Purchaser
SEC Documents as of such dates contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. The financial statements of the Purchaser
included in the Purchaser SEC Documents comply as to form in all material
respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto, have been prepared in accordance
with generally accepted accounting principles consistently applied throughout
the specified period and in the comparable period in the immediately preceding
year ("GAAP") (except as may be indicated in the notes thereto or, in the case
of unaudited statements, as permitted by Rule 10-01 of Regulation S-X) and
present fairly, in all material respects, the consolidated financial position of
Purchaser and its consolidated subsidiaries as of the dates thereof and the
consolidated results of their operations and cash flows for the periods then
ended.
3.4 Absence of Certain Changes or Events. Except as disclosed in the
Purchaser SEC Documents or in Section 3.4 of the Purchaser Disclosure Schedule,
since December 31, 1996, the Purchaser has conducted its business only in the
ordinary course, and there has not been (i) any change which would have a
Purchaser Material Adverse Effect, (ii) any declaration, setting aside or
payment of any dividend or distribution (whether in cash, stock or property)
with respect to any of the Purchaser's outstanding capital stock, (iii) any
split, combination or reclassification of any of the Purchaser's outstanding
capital
23
<PAGE>
stock or any issuance or the authorization of any issuance of any other
securities in respect of, in lieu of or in substitution for shares of its
capital stock, or (iv) any change in accounting methods, principles or practices
by the Purchaser materially affecting its assets, liabilities or business,
except as may have been required by a change in GAAP and would not have a
Purchaser Material Adverse Effect.
3.5 Litigation. Except as disclosed in Section 3.5 of the Purchaser
Disclosure Schedule, there is no action, suit, investigation or proceeding
pending, or, to the knowledge of the Purchaser, threatened, against the
Purchaser or any subsidiary of the Purchaser, at Law or in equity, in, before,
or by any person or entity that has had or would reasonably be expected to have
a material adverse effect on the validity or enforceability of this Agreement or
on the ability of the Purchaser to perform its obligations under this Agreement.
3.6 Brokers. All negotiations relative to this Agreement and the
transactions contemplated hereby have been carried out by the Purchaser directly
with the Sellers, without the intervention of any person on behalf of the
Purchaser in such manner as to give rise to any valid claim by any person
against the Sellers, the Companies or any of their respective subsidiaries for a
finder's fee, brokerage commission, transaction fee, investment banking fee, or
similar payment.
3.7 Purchase for Investment. The PLI Common Stock and CPL Common Stock
will be acquired by the Purchaser for its own account, for investment only and
Purchaser has no present intention of resale or other distribution thereof. The
Purchaser will refrain from transferring or otherwise disposing of any shares of
the PLI Common Stock and CPL Common Stock, or any interest therein, in such
manner as to violate any registration provision of federal or state securities
Laws.
3.8 No Regulatory Disqualifiers. To the knowledge of the Purchaser, no
event has occurred or condition exists or, to the extent it is within the
control of the Purchaser, will occur or exist with respect to the Purchaser,
that in connection with the transactions contemplated by this Agreement would
cause the Purchaser to fail to satisfy any applicable Law of any Insurance
Regulator or other Governmental Entity which prevents or would reasonably be
likely to prevent the Purchaser from obtaining necessary approvals from any
Governmental Entity to consummate the transactions contemplated by this
Agreement.
3.9 Accuracy of Information. No representation or warranty by the
Purchaser contained in this Agreement contains, as of the date of execution of
this Agreement, or will contain on the Closing Date, any untrue statement of a
material fact, or omit or
24
<PAGE>
will omit to state a material fact necessary to make the statements contained
herein and therein, in light of the circumstances under which such statements
are made not misleading.
ARTICLE IV
ADDITIONAL AGREEMENTS
4.1 Access to Information; Confidentiality. Upon reasonable notice, each
of the Sellers shall afford to the Purchaser and to the officers, employees,
counsel, financial advisors and other representatives of the Purchaser
reasonable access during normal business hours during the period prior to the
Closing to all the properties, books, contracts, commitments, personnel and
records of each of the Companies and, during such period, each of the Sellers
shall furnish as promptly as practicable to the Purchaser such information
concerning its business, properties, financial condition, operations and
personnel and such other information regarding affiliates of the Sellers as the
Purchaser may from time to time reasonably request, except to the extent
prohibited by Law or any order, writ, judgment, injunction, decree,
determination or award currently in effect or disclosed in Section 4.1 of the
Seller Disclosure Schedule. Except as required by Law, the Purchaser will hold,
and will cause its respective directors, officers, partners, employees,
accountants, counsel, financial advisors and other representatives and
affiliates to hold, any nonpublic information obtained from the Sellers in
confidence to the extent required by, and in accordance with, the provisions of
the letter dated February 14, 1997, between the Purchaser and DLJ, as exclusive
agent for Leucadia (the "Confidentiality Agreement").
4.2 Commercially Reasonable Efforts. Upon the terms and subject to the
conditions and other agreements set forth in this Agreement, each of the
Sellers, Leucadia Financial, Intramerica, CPF and CPI and the Purchaser agrees
to use commercially reasonable efforts to take, or cause to be taken, all
actions, and to do, or cause to be done, and to assist and cooperate with the
other parties hereto in doing, all things necessary, proper or advisable to
consummate and make effective, in the most expeditious manner practicable, the
transactions contemplated by this Agreement.
4.3 Public Announcements. The Sellers and the Purchaser will consult and
make a good faith effort to agree with each other before issuing, and provide
each other the opportunity to review and comment upon, any press release or
other public statements with respect to this Agreement or the transactions
25
<PAGE>
contemplated by this Agreement, and shall not issue any such press release or
make any such public statement prior to such consultation, except as may be
required by applicable Law, judicial or administrative process or by obligations
pursuant to any listing agreement with any national securities exchange or the
Nasdaq Stock Market.
4.4 Consents, Approvals and Filings. The Sellers and the Purchaser will
make, and the Purchaser and the Sellers will cause their respective subsidiaries
to make, all necessary filings, as soon as practicable, but in no event later
than 45 business days after the date of this Agreement, including, without
limitation, those required under the HSR Act, and applicable state insurance
laws in order to facilitate prompt consummation of the transactions contemplated
by this Agreement; provided that the applications requried to be filed with the
Pennsylvania and Arkansas insurance departments shall be filed, and discussions
with the New York insurance department concerning approval of the reinsurance
agreements required under Section 4.8 of this Agreement shall have commenced, no
later than 37 business days after the date of this Agreement. In addition, the
Sellers and the Purchaser will each use commercially reasonable efforts, and
will cooperate fully with each other (i) to comply as promptly as practicable
with all governmental requirements applicable to the other transactions
contemplated by this Agreement and (ii) to obtain as promptly as practicable all
necessary Permits of Governmental Entities and consents of all third parties
necessary for the consummation of the transactions contemplated in this
Agreement. Each of the Sellers and the Purchaser shall use its commercially
reasonable efforts to promptly provide such information and communications to
Governmental Entities as such Governmental Entities may request.
4.5 Tax Matters.
(a) Subject to Sections 9.3 and 4.5(b) hereof, the Sellers will be
responsible for, will pay or cause to be paid, and will indemnify and hold
harmless the Purchaser from and against, any and all monetary damages,
liabilities, fines, fees, penalties and interest ("Tax Losses") for or in
respect of each of the following:
(i) any Taxes imposed on any of the Companies with respect to any
taxable period of such Company ending on or prior to December 31, 1996
(and not paid by any of the Companies prior to January 1, 1997) to the
extent the aggregate amount of any such Taxes exceeds $12,706,197
("Pre-1997 Taxes"); and
(ii) any Taxes not described in clause (i) of this
Section 4.5(a) and imposed on any of the Companies and
26
<PAGE>
attributable to any member of a consolidated or combined group (other than
the Companies) of which any of the Companies is or was a member on or
prior to the Closing Date and so imposed pursuant to Treasury Regulation
Section 1.1502-6(a) or any analogous or similar state, local or foreign
Law ("Pre-Closing Taxes").
(b) The Purchaser will promptly notify the Sellers of the commencement of
any claim, audit, examination, or other proposed change or adjustment by any
taxing authority concerning any Taxes or other Tax Losses covered by Section
4.5(a) ("Tax Claim"). The Sellers shall control the strategy, defense and
settlement of any Tax audit or administrative or court proceeding relating to
Taxes, including but not limited to extension of the applicable statute(s) of
limitations, of any of the Companies that may be subject to indemnification
under Section 4.5(a) and the Purchaser agrees to fully cooperate with the
Sellers and to cause CPL to fully cooperate with the Sellers, including, but not
limited to, providing powers of attorney authorizing the Sellers (or their
designees) to control and take action in connection with Pre-1997 Taxes and/or
Pre-Closing Taxes. The Sellers shall promptly notify the Purchaser if the
Sellers decide not to participate in the defense of any such Tax audit or
administrative or court proceeding and the Purchaser thereupon shall be
permitted to defend such Tax audit or proceeding; provided, however, that no
settlement shall be made without the prior written consent of the Sellers, which
consent shall not be unreasonably withheld.
The Purchaser expressly acknowledges that the Sellers (and/or their
affiliate(s)) are party to, and have certain rights and obligations under that
certain Stock Purchase and Sale Agreement by and between FPL Group Capital Inc.
(as seller) and Leucadia (as buyer) dated as of April 5, 1991 (the "FPL
Agreement"), and that, pursuant to the FPL Agreement, the Sellers (or their
affiliate(s)) have the right to be indemnified against any loss relating to
specified Taxes of CPL. The Purchaser will take any and all commercially
reasonable steps and will cooperate fully to permit the Sellers (and/or its
affiliate(s)) to comply with its/their obligations and to secure its/their
rights to indemnification under the FPL Agreement, including, but not limited
to, providing powers of attorney authorizing the Sellers (or their designees,
including FPL Group Capital, Inc.) to control and take action in connection with
Pre-1997 Taxes and/or Pre-Closing Taxes, and the Purchaser and CPL agree that
CPL shall not, without the consent of Leucadia, alter, limit or revoke any
powers of attorney executed by CPL prior to the Closing Date in respect of
Pre-1997 Taxes and/or Pre-Closing Taxes. If the Purchaser and/or CPL fail to
take commercially reasonable steps or to fully cooperate with the Sellers in
accordance with this Section 4.5(b), then the Sellers shall not be obligated to
indemnify the Purchaser under Section 4.5(a) for any Tax Losses
27
<PAGE>
attributable to such failure. Subject to the foregoing, Tax Losses for which the
Sellers are required to indemnify the Purchaser pursuant to Section 4.5(a) shall
be so indemnified and paid without regard to whether the underlying amount is
recovered by the Sellers under the FPL Agreement.
(c) The Purchaser and the Companies will be responsible for, will pay or
cause to be paid, and will indemnify and hold harmless the Sellers from and
against, any and all Tax Losses for or in respect of any Taxes (excluding any
Taxes described in clause (i) of Section 4.5(a) hereof) with respect to any
taxable period of any of the Companies ending after December 31, 1996.
(d) Any claim for indemnity hereunder may not be made after the expiration
of the applicable Tax statute of limitations with respect to the relevant
taxable period (including all periods of extension, whether automatic or
permissive).
(e) Except as provided in the succeeding sentences, as of the Closing Date
none of the Companies shall be a party to or have any further obligations or
rights under the tax sharing or tax allocation agreement with the Sellers and
their affiliates, a copy of which has been provided to Purchaser (the "Tax
Sharing Agreement"), which agreement shall be terminated as between such
parties. If any Company is included in a Seller Consolidated Return (as defined
below) for the period commencing January 1, 1997, within ninety days after the
Closing Date, the Sellers shall provide the Purchaser with a schedule setting
forth the liability of any such Company for Taxes, or the amount of any Tax
refund owed to any such Company, for the Sellers' 1997 taxable year computed in
accordance with the Tax Sharing Agreement ("Final Tax Sharing Payment"). If the
Purchaser disputes the Final Tax Sharing Payment, the Purchaser shall advise the
Sellers of its objections to the Final Tax Sharing Payment in writing within 15
days of the receipt thereof. The Sellers and the Purchaser shall negotiate in
good faith to resolve any such written objections to the Sellers' computation of
the Final Tax Sharing Payment. If such disputes are not resolved within thirty
days, any remaining disputes shall be referred to a big six accounting firm (the
"Auditor") which is mutually acceptable to the Sellers and the Purchaser for
resolution. The Auditor shall issue a written report which sets forth the Final
Tax Sharing Payment as finally determined. Within five days of the Final Tax
Sharing Payment being finally determined (whether pursuant to agreement or
through the Auditor's determination), each Company shall pay its allocable share
of the Final Tax Sharing Payment to the Sellers, or the Sellers shall pay its
allocable share of the Final Tax Sharing Payment to the appropriate Company, as
the case may be. Fees and expenses of the Auditor shall be shared equally by
Sellers, on the one hand, and Purchaser.
28
<PAGE>
(f) The Sellers shall prepare and file or cause to be prepared and filed,
(i) all Tax Returns required to reflect the income, assets or operations of the
Companies and required to be filed (taking into account any extensions) on or
prior to the Closing Date and any Tax Returns required to be filed thereafter in
respect of any Taxes for which Sellers are responsible pursuant to Section
4.5(a), and (ii) all Seller Consolidated Returns (together with the Tax Returns
referred to in clause (i) above, the "Seller Returns"). The Purchaser shall be
responsible for preparing or filing, or causing the Companies to prepare and
file, all other Tax Returns required to be filed by any of the Companies after
the Closing Date ("Other Returns"). The Purchaser shall provide the Sellers with
the opportunity to review and comment upon the Other Returns (to the extent such
Other Returns may give rise to a claim for indemnification against the Sellers
hereunder or could affect Pre-1997 Taxes or Pre-Closing Taxes or Tax Returns) at
least ten business days prior to the filing thereof. "Seller Consolidated
Returns" shall mean all consolidated or combined Tax Returns which include the
taxable income or loss of any of the Companies on the one hand and any of the
Sellers and/or affiliates (other than the Companies) of the Sellers, on the
other hand.
(g) Neither the Purchaser nor any of the Companies shall file any amended
Tax Return which may give rise to a claim for indemnification hereunder without
the prior written consent of the Sellers. The Sellers shall have exclusive
authority to make all decisions with respect to matters relating to any Seller
Return, including, but not limited to, decisions to amend a Seller Return, to
extend the statutes of limitations with respect to any periods covered by a
Seller Return, and to concede, settle, compromise or contest any adjustment
asserted by a taxing authority with respect to a Seller Return.
(h) The Sellers and the Purchaser will cooperate with one another in
connection with the preparation and filing of Seller Returns and Other Returns
and will provide to each other access, at any reasonable time and from time to
time, at the business location at which the books and records are maintained,
after the Closing Date, to such Tax data relating to the Companies as Sellers or
Purchaser, as the case may be, may from time to time reasonably request
(including the relevant portions of Seller Consolidated Returns).
(i) Sellers shall be entitled to receive and to retain any and all refunds
of Taxes (i) relating to Seller Returns (including any refunds of Taxes arising
from a carryback of losses by any of the Companies) or (ii) in respect of any of
the Companies for any taxable period ending on or prior to December 31, 1996,
including, without limitation, a refund of any amount of Taxes paid by CPL and
currently the subject of dispute
29
<PAGE>
with the Internal Revenue Service or any other Governmental Entity. In the event
the Purchaser receives any refund (whether through payment, credit or reduction
in Taxes) to which the Sellers are entitled hereunder, the Purchaser shall
promptly pay, or cause the payment of, such refund to the Sellers.
(j) No election shall be made under Section 338(h)(10) of the Code with
respect to the purchase of the Shares of the Companies hereunder.
(k) Notwithstanding anything to the contrary contained herein, in
calculating the amount of any claim for indemnification pursuant to this
Agreement (including pursuant to this Section 4.5 and Article IX hereof), Tax
Losses and Damages (as defined in Section 9.1 hereof) shall be reduced by any
Tax Benefit attributable to, realized (or to be realized) in connection with or
relating to such indemnifiable claim. The term "Tax Benefit" means the amount by
which any Taxes of the Purchaser or any of the Companies or any affiliate
thereof (the "Benefitted Party") are or would be reduced by any loss, deduction,
refund, credit or other Tax benefit and includes, without limitation, an
Offsetting Tax Benefit. The term "Offsetting Tax Benefit" means the amount of
any Tax Benefit realized or to be realized by the Benefitted Party in a
subsequent taxable period (including, without limitation, a taxable period
ending after the Closing Date) attributable to, realized (or to be realized) in
connection with or relating to an adjustment with respect to Taxes in a prior
taxable period. For purposes of the determination of the amount of any Tax
Benefit which is not currently realized, (i) the Benefitted Party shall be
assumed to have sufficient taxable income to use any Tax Benefit in the taxable
period or periods in which such Tax Benefit will first arise; (ii) the Effective
Tax Rate (as hereinafter defined) in the most recent applicable taxable period
shall be treated as applying to such Tax Benefit to be realized in such future
taxable period; (iii) the amount of Tax Benefits shall be discounted to the
present value of such Tax Benefits, determined using a discount rate equal to
the applicable federal rate under Section 1274(d) of the Code for the period
over which such Tax Benefits are assumed to be realized under clause (i) above;
and (iv) appropriate adjustments shall be made taking account of any income
recognition resulting from such Tax Benefit for any of the Companies in any
period covered by the Other Returns, using the assumptions and discounting
convention provided in this Section 4.5(k). The term "Effective Tax Rate" means
the sum of (i) the maximum federal income tax rate imposed on corporations for
the period in question plus (ii) the product of (A) the weighted average of the
maximum state and local income tax rates imposed by all jurisdictions entitled
to tax income of the applicable corporation times (B) one minus the maximum
federal income tax rate referred to in clause (i).
30
<PAGE>
(l) Interest will accrue on any Tax claims beginning the earlier of (i)
the date such amount was received if owing to the other party, or (ii) 30 days
after a written claim has been made to the indemnifying party. Interest shall
accrue at the applicable rate charged by the Internal Revenue Service for
overpayments.
4.6 Employee Benefit Matters.
(a) Effective as of the Closing Date, CPG and CPL shall take all necessary
actions to ensure that CPL ceases to be a participating Employer in the Colonial
Penn Group, Inc. Retirement Plan as the term is defined in the Colonial Penn
Group, Inc. Retirement Plan.
(b) Prior to the Closing Date, the Sellers shall take all necessary
actions to cause CPL to establish a Plan which is a 401(k) plan ("401(k) Plan"),
and a trust for the purpose of providing benefits thereunder ("401(k) Trust"),
which, in all material respects, provide the same benefits, rights and features
as the Colonial Penn Group Savings Plan and Trust, and which 401(k) Plan and
401(k) Trust, to the knowledge of the Sellers, satisfies the applicable
requirements of Section 401 of the Code, and is exempt from Federal income Taxes
pursuant to Section 501 of the Code. Such 401(k) Plan and 401(k) Trust shall be
used to provide benefits to current employees of the Companies who were eligible
to participate in the Colonial Penn Group Savings Plan prior to the Closing
Date. Effective as soon as reasonably practicable following the Closing Date (or
such earlier date as Sellers shall determine, with the consent of the Purchaser,
which shall not be unreasonably withheld) the Sellers and the Purchaser shall
take all necessary actions to cause the Colonial Penn Group Savings Plan and the
Trust used to fund benefits thereunder to transfer in kind the balances of each
such current employees' account to the 401(k) Plan and 401(k) Trust. Prior to
the transfer, Purchaser shall not amend the 401(k) Plan and 401(k) Trust in any
material respect.
(c) Prior to the Closing Date, the Sellers shall take all necessary
actions to cause CPL to establish a Benefit Plan which is a non-qualified
deferred compensation plan ("NQ Plan") which, in all material respects, provides
the same benefits, rights and features as the Colonial Penn Insurance Company
Salary Cap Restoration Plan. Such NQ Plan shall be used to provide benefits to
current employees of the Companies who were eligible to participate in the
Colonial Penn Insurance Company Salary Cap Restoration Plan prior to the Closing
Date. Effective immediately prior to the Closing Date, Sellers shall take all
necessary actions to cause the Colonial Penn Insurance Company Salary Cap
Restoration Plan to transfer the liabilities of such employees to the NQ Plan.
31
<PAGE>
(d) Prior to the Closing Date, the Sellers shall take all necessary
actions to cause CPL to assume liability for the disability benefits, and the
life insurance benefits, if any, earned by those former employees of the
Companies or any predecessor thereto listed in Section 4.6 of the Seller
Disclosure Schedule.
(e) Leucadia agrees to use its best efforts to cause the group annuity
contracts held by the trustees, pension committee or trust, all as listed in
Section 2.6.5 of the Seller Disclosure Schedule, to be maintained with CPL until
January 2, 1998 if Conseco is able to provide assurances to the respective
trustees or pension committee and their respective counsel that such action is
consistent with the fiduciary duties of such persons. The Purchaser acknowledges
that such best efforts undertaking shall not restrict Leucadia's right to sell
any of its property and casualty insurance operations.
4.7 Reinsurance of Certain Health Insurance Policies. Effective prior to
the Closing Date, CPF and CPI shall cede to CPL, and CPL shall reinsure from CPF
and CPI, on a 100% coinsurance basis, the accident and health insurance policies
of CPF and CPI identified in Section 4.7 of the Seller Disclosure Schedule (the
"A&H Policies"), all under and pursuant to the terms of reinsurance agreements
in the form attached hereto as Exhibit C (the "A&H Coinsurance Treaties").
4.8 Intramerica Reinsurance.
(a) Effective as of the Closing Date, Intramerica shall cede to CPL , and
CPL shall reinsure from Intramerica, the insurance policies identified in
Section 4.8 of the Seller Disclosure Schedule having policyholders domiciled in
the State of New York (the "NY Policies"), with all reserve assets relating
thereto being placed in trust, all under and pursuant to a reinsurance agreement
in the form attached hereto as Exhibit D (the "NY Reinsurance Treaty"). As set
forth therein, the NY Reinsurance Treaty will initially provide for reinsurance
of the NY Policies on a 100% coinsurance basis; provided, however, that such
reinsurance will convert to an assumption reinsurance basis with American
Travellers Insurance Company of New York, a New York stock corporation and
affiliate of the Purchaser ("Purchaser's NY Affiliate") as the assuming
reinsurer at the earliest time practical under the circumstances, with due
regard for any required regulatory or policyholder consents or approvals
incident to such assumption transaction ("Assumption Approvals"). Following the
Closing, each of Purchaser and Purchaser's NY Affiliate agree to use
commercially reasonable efforts to secure the Assumption Approvals, including
all approvals or licenses required of Purchaser's NY Affiliate, as quickly as
possible. The Purchaser and Purchaser's NY Affiliate shall keep Sellers
32
<PAGE>
informed of the progress of the Assumption Approvals and shall provide Sellers
with copies of all information submitted to any Insurance Regulator in
connection with the Assumption Approvals as Sellers shall reasonably request. It
is the intention of the parties that arrangements shall be effected pursuant to
which Purchaser shall acquire substantially all of the operations and
substantially all of the personnel of Intramerica's Orangeburg, New York
facility (the "Orangeburg Facility"), and shall assume the lease for the
Orangeburg Facility and the severance obligations for all employees so acquired.
(b) Effective as of the Closing Date, Intramerica shall cede to CPL, and
CPL shall reinsure from Intramerica, the insurance policies identified in
Section 4.8 of the Seller Disclosure Schedule having policyholders domiciled
outside of the State of New York (the "Non-NY Policies"), all under and pursuant
to a reinsurance agreement in the form attached hereto as Exhibit E (the "Non-NY
Reinsurance Treaty").
(c) Effective on the Closing Date, Purchaser, or at Purchaser's election,
an insurance company affiliate having capital and surplus of at least $200
million, shall unconditionally guarantee the obligations of CPL and/or
Purchaser's NY Affiliate to Intramerica under the NY Reinsurance Treaty and
Non-NY Reinsurance Treaty pursuant to a guaranty agreement in the form attached
hereto as Exhibit F (the "Reinsurance Guaranty").
(d) The Purchaser shall cooperate with the Sellers and Intramerica in
obtaining the approval of the New York Insurance Department of a $25 million
extraordinary dividend payable on or before the Closing Date by Intramerica to
the shareholders of Intramerica (the "NY Dividend"); provided that if Purchaser,
in good faith, believes that the request for the N.Y. Dividend is resulting in
unreasonable delay in obtaining approvals for the transactions otherwise
contemplated hereby, Sellers and Intramerica shall defer the request for the NY
Dividend so as not to unreasonably delay such approvals.
4.9 Intercompany Agreements.
(a) Each intercompany agreement between any Seller or any of its
affiliates (other than the Companies), on the one hand, and any of the
Companies, on the other hand, relating to the operation of the insurance
business of any of the Companies or any Seller (or such Seller's affiliates)
(the "Intercompany Operations Agreements"), shall be amended to provide for the
continuation of such contracts for a period of 18 months, subject to termination
upon not more than 90 days notice, and at rates that are substantially the same
as the rates charged for the period from January 1, 1997 to March 31, 1997,
provided, however,
33
<PAGE>
that (i) such contracts shall be reviewed by the parties hereto and shall, as
the party to whom services are provided may determine in good faith, be
terminated, amended, or left intact. All balances owed to any party pursuant to
any Intercompany Operations Agreements to be terminated shall be paid within 30
days following termination of such agreements and (ii) all Intercompany
Operations Agreements between Leucadia and any of the Companies shall terminate
effective on the Closing Date, unless otherwise provided within the Agreement.
All other intercompany agreements not relating to the operation of the Companies
shall terminate effective on the Closing Date except as set forth in Section
4.5(e) of this Agreement or in Section 4.9(a) or 4.9(b) of the Seller Disclosure
Schedule. All balances owed to the Sellers or any of their affiliates (other
than the Companies) from any of the Companies pursuant to any intercompany
agreement to be terminated shall be paid prior to the Closing Date (except as
otherwise set forth in Section 4.5(e) of this Agreement).
(b) Pursuant to the provisions of Article I hereof, at the Closing,
Leucadia Financial shall assign to the Purchaser the agreements listed in
Section 4.9(b) of the Seller Disclosure Schedule, and the Purchaser shall assume
all obligations of Leucadia Financial thereunder and shall hold Leucadia
Financial harmless with respect to any and all obligations thereunder.
(c) At the Closing, the Companies, on the one hand, and CPI, CPF,
Intramerica, CNL, Inc., Leucadia Financial, Charter, and any other affiliates of
the Sellers deemed appropriate by the Sellers, on the other hand, shall enter
into an Administrative Services Agreement having terms and conditions mutually
agreeable to the parties hereto. Such agreement shall (i) provide for the
continuation at the allocated cost thereof of certain administrative,
accounting, actuarial and other services currently provided between or among
such companies as may be necessary to effectuate the orderly transition
resulting from the purchase of the Companies by the Purchaser and the other
transactions contemplated by this Agreement for a period of time not to exceed
18 months from the Closing Date and (ii) be terminable, with respect to any such
service, upon not less than 60 days' prior written notice (except for data
processing services currently provided under the Data Services Agreement, dated
January 1, 1997, between CPI and CPL, which shall require not less than 180
days' prior written notice) deliverable solely by the party receiving such
service. The parties hereto agree to negotiate the terms of such agreement in
good faith.
4.10 Limited License; Trademark Ownership and Protection:
Change of Name.
34
<PAGE>
(a) At the Closing, an affiliate of Leucadia and the Purchaser shall enter
into a licensing agreement in the form attached hereto as Exhibit G (the
"License Agreement") pursuant to which the affiliate, as licensor, will grant to
Purchaser, as licensee ("Licensee"), a personal, non-transferable, non-exclusive
license (the "License"), without the right to sublicense except as provided
therein, to use the trademarks, service-marks and/or trade-names listed in
Section 4.10 of the Seller Disclosure Schedule in connection with those products
and services listed in Section 4.10 of the Seller Disclosure Schedule within the
United States of America during a period from the Closing Date to but not
including the 18th month anniversary of the Closing Date (the "Initial License
Term"). Sellers shall cause its affiliate to enter into the License Agreement.
Notwithstanding the foregoing, if at the Closing Date, Seller's affiliate shall
have transferred all of its right, title and interest in and to the trademarks,
service-marks and/or tradenames listed in Section 4.10 of the Seller Disclosure
Schedule, such transferee shall enter into the License Agreement. Sellers agree
that they shall not transfer such rights prior to the Closing Date unless such
transferee agrees to enter into the License Agreement, which agreement shall be
for the benefit of Conseco. The License Agreement shall provide that following
the Initial License Term CPL may continue with its current name and use the
License in connection with premium collections and maintenance of polices of CPL
existing at the end of the Initial License Term; provided, however, that CPL may
not use the words "Colonial," "Penn" or "Colonial Penn" after the Initial
License Term in connection with marketing of any products, including, without
limitation, add-ons or upgrades of existing policies of CPL.
(b) The Purchaser and the Companies acknowledge that except as provided in
the License Agreement, neither the Purchaser or any of the Companies shall have
the right to use the trademarks, service-marks and/or trade-names referred to in
clause (a) above and shall have no right to limit or restrict the Sellers (or
any affiliate or any assignee or transferee of any of them) from using the same
or the words "Colonial" or "Penn" or "Colonial Penn" except that the Sellers
agree that following the Closing Date, any life insurance products marketed or
sold by any of them or any affiliate shall be issued by an entity that does not
have the words "Colonial," "Penn" or "Colonial Penn" in its corporate name and
does not use such words in any life insurance product name and that following
the date hereof it will not sell, assign or transfer any rights to use the words
"Colonial", "Penn" or "Colonial Penn" in connection with the insurance business
without obtaining from the purchaser, assignee or transferee of such rights an
agreement to be bound by the foregoing restriction.
35
<PAGE>
(c) The Sellers agree that following the Closing Date, they shall not hire
or otherwise employ Ed McMahon, Lou Rawls or Alex Trebek as celebrity endorsers
in connection with the marketing of any insurance products (except with respect
to activities permitted under the reinsurance agreements to be entered into
pursuant to Article IV hereof).
(d) At the Closing, the Sellers shall transfer to Purchaser, in such
manner as is satisfactory to Purchaser, the trademarks, service-marks and/or
tradenames listed in Section 4.10(a) of the Seller Disclosure Schedule.
4.11 Standby L/C. The Purchaser covenants that until such time as each of
the Purchaser Notes shall have been irrevocably paid in full, Purchaser shall
maintain or cause to be maintained each Standby L/C.
4.12 Hiring of Employees. Except (a) for those employees whose names are
set forth in Section 4.12 of the Company Disclosure Schedule or (b) persons
noticed for termination, for a 36 month period following the Closing Date, the
Sellers shall not solicit for employment or knowingly hire any employees of the
Companies or any of their subsidiaries. Seller shall be responsible for all
obligations to the employees named in Section 4.12 of the Seller Disclosure
Schedule under the letters from CPL to such employees dated March 1997 listed on
Section 2.8.2 of the Seller Disclosure Schedule.
4.13 Marketing Database. Prior to the Closing, the parties shall cooperate
with each other to separate the marketing databases of the Companies and CPI.
Prior to the Closing, CPI and CPL each shall enter into separate agreements with
Metromail, the servicer of such databases. Prior to the Closing, the marketing
database of the Companies shall consist of approximately 5.78 million names as
to which the Companies shall have exclusive use and approximately 9.6 million
names as to which the Companies shall have non-exclusive use (together with
CPI).
4.14 Leucadia Stock Options. The treatment at the Closing Date of options
to purchase capital stock of Leucadia held by employees of the Companies shall
be determined by Leucadia prior to the Closing Date. All obligations with
respect to such options shall be the responsibility of Leucadia.
4.15 Resignations of Directors. Sellers will cause (a) such members of the
Board of Directors of the Companies and, (b) such members of the Boards of
Directors, as are designated by Purchaser to tender, effective at the Closing
Date, their resignations from such Boards of Directors or offices and, if
36
<PAGE>
requested by Purchaser, will cause the election of Purchaser's nominees to such
Boards of Directors and offices.
ARTICLE V
COVENANTS RELATING TO CONDUCT OF BUSINESS PRIOR TO CLOSING
5.1 Conduct of Business by the Companies. Except as contemplated by this
Agreement or as set forth in Section 5.1 of the Seller Disclosure Schedule,
during the period from the date of this Agreement to the Closing, the Sellers
shall cause the Companies to act and carry on their respective businesses in the
ordinary course and, to the extent consistent therewith, use reasonable efforts
to preserve intact their current business organizations, keep available the
services of their current key officers and employees and preserve the goodwill
of those engaged in material business relationships with them. Without limiting
the generality of the foregoing, during the period from the date of this
Agreement to the Closing Date, except as set forth in Section 5.1 of the Seller
Disclosure Schedule or except as otherwise contemplated under this Agreement,
the Sellers shall not permit any of the Companies to, without the prior consent
of the Purchaser:
(a) (i) declare, set aside or pay any dividends on, or make any
other distributions (whether in cash, stock or property) in respect of,
any of such Company's outstanding capital stock, (ii) split, combine or
reclassify any of its outstanding capital stock or issue or authorize the
issuance of any other securities in respect of, in lieu of or in
substitution for shares of its outstanding capital stock, or (z) purchase,
redeem or otherwise acquire any shares of outstanding capital stock or any
rights, warrants or options to acquire any such shares;
(b) issue, sell, grant, pledge or otherwise encumber any shares
of its capital stock, any other voting securities or any securities
convertible into, or any rights, warrants or options to acquire, any such
shares, voting securities or convertible securities;
(c) amend its articles or certificate of
organization, by-laws or other comparable charter or
organizational documents;
(d) acquire, form or commence the operations of
any business or any corporation, partnership, joint venture,
association or other business organization or division
thereof;
37
<PAGE>
(e) sell, mortgage or otherwise encumber or subject to any Lien
or otherwise dispose of any of its assets that are material to the
Companies taken as a whole;
(f) (x) incur any indebtedness for borrowed money or guarantee
any such indebtedness of another person, other than indebtedness owing to
or guarantees of indebtedness owing to such Company or (y) make any loans
or advances to any other person, other than to any of the Companies and
other than loans or advances incurred in the ordinary course of business;
(g) except with respect to Taxes, which shall be governed under
Article IV hereof, discharge, settle or satisfy any claims, liabilities or
obligations (absolute, accrued, asserted or unasserted, contingent or
otherwise), other than the payment, discharge or satisfaction, in the
ordinary course of business consistent with past practice or in accordance
with their terms, of liabilities reflected or reserved against in, or
contemplated by, the most recent Company Annual Statements (or the notes
thereto) of such Company or incurred since the date of such Company Annual
Statements in the ordinary course of business consistent with past
practice;
(h) invest their future cash flow, any cash from matured and
maturing investments, any cash proceeds from the sale of their assets and
properties, and any cash funds currently held by them, in any investments
other than cash equivalent assets or in investments having a duration not
in excess of three years (consisting of United States government issued or
guaranteed securities, or commercial paper rated A-1, or P-1), except (w)
as otherwise required by law, (x) as required to provide cash (in the
ordinary course of business and consistent with past practice) to meet its
actual or anticipated obligations (y) publicly-traded corporate bonds that
are rated investment grade by at least two nationally recognized
statistical rating organizations or (z) with respect to the agreement set
forth in Section 5.1 (h) of the Seller Disclosure Schedule,;
(i) except as may be required by Law or as
otherwise provided in this Agreement;
(i) make any representation or promise, oral or written, to any
employee or former director, officer or employee of such Company
which is inconsistent with the terms of any Benefit Plan;
(ii) except for ordinary salary and wage increases in
the ordinary course of business and consistent with
38
<PAGE>
past practices, make any change to, or amend in any way, the
contracts, salaries, wages, or other compensation of any employee or
any agent or consultant of such Company other than changes or
amendments that are required under existing contracts as disclosed
in the Seller Disclosure Schedule;
(iii) adopt, enter into, amend, alter or terminate, partially or
completely, any Benefit Plan or any election made pursuant to the
provisions of any Benefit Plan, to accelerate any payments,
obligations or vesting schedules under any Benefit Plan; provided,
however, that nothing contained in this Agreement shall prevent
Sellers from taking such actions as they deem necessary or desirable
to effectuate the transfer of the liabilities under each such
Benefit Plan attributable to participants who are active employees
of Sellers or Intramerica on such Closing Date together with an
allocable share of any funding media thereto to another benefit plan
or program sponsored by Sellers, CPI or Intramerica; or
(iv) approve any general or company-wide pay
increases for employees;
(j) except in the ordinary course of business, modify, amend or
terminate any material agreement, permit, concession, franchise, license
or similar instrument to which such Company is a party or waive, release
or assign any material rights or claims thereunder;
(k) move the operations of any business or
division to any location other than where it is located on
the date hereof; or
(l) authorize any of, or commit or agree to take
any of, the foregoing actions.
5.2 Other Actions.
(a) The Sellers and the Purchaser shall not, and shall not permit any of
their respective subsidiaries to, take any action that would, or that could
reasonably be expected to, result in (i) any of the representations and
warranties of such party set forth in this Agreement becoming untrue in any
material respect or (ii) any of the conditions to the transactions contemplated
hereby set forth in Article VI not being satisfied.
(b) The Sellers shall not, to the extent practicable, permit any of the
Companies to, without the prior consent of Purchaser, hold any meeting of the
board or directors of the
39
<PAGE>
Companies or any subsidiary or any committee of any such board, or take any
action by written consent of any such board of committee, without providing (i)
notice of any such meeting no later than the date notice is given to the board
of directors or in advance of the date of any proposed action by written consent
and (ii) with such notice, an agenda of the specific matters intended to be
considered at such meeting or a copy of the proposed written consent, unless, in
the reasonable good faith judgment of the Sellers, providing prior notice of any
agenda item or any item of such written consent will prejudice the ability of
the board of directors or any committee of the board of directors to discharge
its duties, in which case such item may be omitted from the agenda or written
consent provided to the Purchaser; provided, that such item does not relate to a
matter that is or would be a violation of this Agreement.
ARTICLE VI
CONDITIONS PRECEDENT
6.1 Conditions to Each Party's Obligation To Consummate Transactions. The
respective obligation of each party to this Agreement to consummate the
transactions contemplated by this Agreement is subject to the satisfaction or
waiver on or prior to the Closing Date of the following conditions:
(a) Governmental and Regulatory Consents. All required consents,
approvals, permits and authorizations to the consummation of the transactions
contemplated hereby shall have been obtained from the Insurance Regulators in
the jurisdictions set forth in Section 6.1 of the Seller Disclosure Schedule.
(b) HSR Act. The waiting period (and any extension thereof)
applicable to the transactions contemplated hereby under the HSR Act shall have
been terminated or shall have otherwise expired.
(c) No Injunctions or Restraints. No temporary restraining order,
preliminary or permanent injunction or other order issued by any court of
competent jurisdiction or other legal restraint or prohibition preventing the
consummation of the transactions contemplated hereby shall be in effect or
threatened; provided, however, that any party invoking this condition shall use
commercially reasonable efforts to have any such order or injunction vacated.
6.2 Conditions to Obligations of the Purchaser. The obligation of the
Purchaser to consummate the transactions contemplated hereby is further subject
to the following conditions:
40
<PAGE>
(a) Representations and Warranties. The representations and
warranties of the Sellers contained in this Agreement shall have been true and
correct on the date of this Agreement and as of the Closing Date (except to the
extent that they expressly relate only to an earlier time, in which case they
shall have been true and correct as of such earlier time and except for actions
contemplated by this Agreement), other than such breaches of representations and
warranties which in the aggregate would not have a Company Material Adverse
Effect. The Sellers shall have delivered to the Purchaser a certificate, dated
the Closing Date and signed on behalf of each Seller by an authorized officer of
such Seller respective to the foregoing effect with respect to the
representations and warranties of the Sellers.
(b) Performance of Obligations of the Company. The Sellers shall
have performed in all material respects all obligations required to be performed
by them under this Agreement on or prior to the Closing Date and the Purchaser
shall have received a certificate dated as of the Closing Date signed on behalf
of each Seller by an authorized officer of such Seller to such effect.
6.3 Conditions to Obligations of the Sellers. The obligations of the
Sellers to consummate the transactions contemplated hereby is further subject to
the following conditions:
(a) Representations and Warranties. The representations and warranties of
the Purchaser contained in this Agreement shall have been true and correct on
the date of this Agreement and as of the Closing Date (except to the extent that
they expressly relate only to an earlier time, in which case they shall have
been true and correct as of such earlier time), other than such breaches of
representations and warranties which in the aggregate would not have a Purchaser
Material Adverse Effect. The Purchaser shall have delivered to the Sellers a
certificate, dated the Closing Date and signed on its behalf by an authorized
officer of the Purchaser to the foregoing effect with respect to the
representations and warranties of the Purchaser.
(b) Performance of Obligations of the Purchaser. The Purchaser shall have
performed in all material respects all obligations required to be performed by
it under this Agreement on or prior to the Closing Date and the Company shall
have received a certificate dated as of the Closing Date signed on behalf of the
Purchaser by an authorized officer of the Purchaser.
(c) Purchaser Notes. The Purchaser shall have duly
executed and delivered to CP Holdings the Purchaser Notes.
41
<PAGE>
(d) Standby L/C. The Purchaser shall have delivered to CP Holdings each of
the Standby L/C's, fully executed by all necessary parties, which shall be in
full force and effect.
ARTICLE VII
TERMINATION, AMENDMENT AND WAIVER
7.1 Termination. This Agreement may be terminated and
abandoned at any time prior to the Closing Date:
(a) by mutual written consent of the Purchaser and the
Sellers; or
(b) by either the Purchaser or the Sellers:
(i) at any time after September 30, 1997, if the transactions
contemplated hereby shall not have been consummated by such date, unless
the failure to consummate such transactions is the result of a willful and
material breach of this Agreement by the party seeking to terminate this
Agreement; or
(ii) if any Governmental Entity shall have issued an order,
decree or ruling or taken any other action permanently enjoining,
restraining or otherwise prohibiting the transactions contemplated by this
Agreement and such order, decree, ruling or other action shall have become
final and nonappealable.
7.2 Effect of Termination. In the event of termination of this Agreement
by either the Sellers or the Purchaser as provided in Section 7.1, this
Agreement shall forthwith become void and have no effect, without any liability
or obligation on the part of the Purchaser or the Sellers, other than with
respect to the last sentence of Section 4.1, and Sections 2.15, 3.6 and 7.2 of
this Agreement. Nothing contained in this Section shall relieve any party from
any liability resulting from any material willful breach of the representations,
warranties, covenants or agreements set forth in this Agreement.
ARTICLE VIII
SURVIVAL OF PROVISIONS
8.1 Survival. The representations and warranties required
to be made by the Sellers and the Purchaser in this Agreement or
42
<PAGE>
in any certificate delivered pursuant hereto will survive the
Closing as follows:
(a) in the case of the representations and warranties of Sellers set
forth in Section 2.2(b) and in Section 2.7 hereof, until 30 days after the
expiration of statutes of limitation applicable in each such Section; and
(b) in the case of all other representations and
warranties, until March 31, 1999.
Notwithstanding the foregoing, any representation or warranty shall
survive the time it would otherwise terminate pursuant to this Section 8.1 to
the extent that notice of a breach thereof giving rise to a right of
indemnification shall have been given by a party hereto prior to the expiration
of the relevant survival period in accordance with Article IX or Section 4.5 of
this Agreement.
ARTICLE IX
INDEMNIFICATION
9.1 Indemnification by Sellers. Subject to the provisions of Sections 8.1,
9.3, and 9.4 hereof, the Sellers will indemnify and hold harmless the Purchaser
for any and all monetary damages, charges, losses, deficiencies, liabilities,
obligations, costs, fees, and expenses (including, without limitation,
reasonable fees and disbursements of counsel incident to the enforcement of
rights under Section 9.1 or 9.2 hereof) (collectively, "Damages") resulting from
or relating to any breach by the Sellers, Leucadia Financial, Intramerica, CPF
or CPI of any representation, warranty, covenant, or agreement made by the
Sellers in this Agreement. Notwithstanding the foregoing, indemnification for
Tax Losses shall be governed by Section 4.5 hereof.
9.2 Indemnification by the Purchaser. Subject to the provisions of
Sections 8.1, 9.3, and 9.4 hereof, the Purchaser will indemnify and hold
harmless each Seller in respect of any and all Damages resulting from or
relating to any breach by the Purchaser of any representation, warranty,
covenant, or agreement made by the Purchaser in this Agreement. Notwithstanding
the foregoing, indemnification for Tax Losses shall be governed by Section 4.5
hereof.
9.3 Limitations on Indemnification.
(a) No claim by any person for indemnification under this Article IX (an
"Indemnitee") against any person (an "Indemnifying Party"), which claim relates
to a breach of a representation or
43
<PAGE>
warranty made in this Agreement may be made unless notice of such breach is
given in accordance with this Article IX prior to the time the survival period
for such representation or warranty expired.
(b) No claim by the Purchaser under Section 9.1, or by the Sellers under
Section 9.2, for indemnification may be made unless and until the Purchaser or
the Sellers, as the case may be, have incurred Damages in excess of $2,500,000
in the aggregate for the Purchaser or the Sellers, respectively, at which time,
all amounts of Damages in excess of $2,500,000 may be claimed and recovered as
provided in this Agreement; provided, however, that the foregoing limitation
shall not apply to (i) Damages attributable to a breach by any Seller of any
representation made by such Seller with respect to its title to the issued and
outstanding shares of PLI Common Stock, the shares of capital stock of PLI's
subsidiaries set forth in Section 2.2 of the Seller Disclosure Schedule and CPL
Common Stock or (ii) intentional breaches of any covenant or agreement set forth
in Article IV or Article V. The foregoing limitation contained in this Section
9.3(b) shall not in any way restrict or limit the right of any holder of a
Purchaser Note to enforce payment of such Purchaser Note or the Standby L/C
supporting such Purchaser Note. Notwithstanding the foregoing, (i) no party
shall be required to pay indemnification hereunder for any individual Damages
claim involving less than $5,000 and (ii) any claim for a breach of the
representation contained in Section 2.3 hereof as the same relates to CP Real
Estate shall be subject to a $100,000 indemnification deductible rather than the
$2,500,000 level set forth above. In determining whether a representation or
warranty made under Article II or Article III hereof has been breached and
Damages suffered as a result, for purposes of this Article IX, such
representation or warranty shall be deemed to exclude any exception thereto
which refers to Company Material Adverse Effect (with respect to Article II) or
Purchaser Material Adverse Effect (with respect to Article III).
(c) Notwithstanding anything to the contrary contained in this Agreement,
neither the Purchaser, on the one hand, nor the Sellers, on the other hand, will
be liable under any circumstances for indemnification under Section 9.1 or
Section 9.2 hereof, respectively, in an aggregate amount in excess of
$50,000,000; provided, however, that the foregoing limitation shall not apply to
(i) Damages attributable to a breach by any Seller of any representation made by
such Seller with respect to its title to the issued and outstanding shares of
PLI Common Stock, the shares of capital stock of PLI's subsidiaries set forth in
Section 2.2 of the Seller Disclosure Schedule and CPL Common Stock or (ii)
intentional breaches of any covenant or agreement set forth in Article IV or
Article V. The foregoing limitation contained in this Section 9.3(c) shall not
in any way
44
<PAGE>
restrict or limit the right of any holder of a Purchaser Note to enforce payment
of such Purchaser Note or the Standby L/C supporting such Purchaser Note. As to
amounts payable by the Sellers hereunder, the Sellers, at their election, may
require the Purchaser, in lieu of receiving payment from the Sellers, to offset
such amounts against the Purchaser's obligations under the Purchaser Notes to
pay principal and/or interest (as specified by the Sellers).
(d) If an Indemnitee recovers from any third party (including insurers)
all or any part of any amount paid to it by an Indemnifying Party pursuant to
Section 9.1, Section 9.2 or Section 4.5 hereof, such Indemnitee will promptly
pay over to the Indemnifying Party the amount so recovered (after deducting
therefrom the full amount of the expenses incurred by it in procuring such
recovery, including any Taxes and net of any Tax Benefit resulting from such
recovery and payment), but not in excess of any amount previously so paid by the
Indemnifying Party. If an Indemnitee recovers from any third party (including
insurers) any amount as to which indemnification may be claimed pursuant to
Section 9.1, Section 9.2 or Section 4.5 hereof, such Indemnitee will have no
right to claim indemnification for such amount from the Indemnifying Party.
(e) Subject to Section 4.5 hereof, the Indemnitee will prosecute
diligently and in good faith any claim for indemnification with any applicable
third party (including insurers) prior to collecting any indemnification payment
pursuant to Section 9.1 or 9.2 hereof.
9.4 Notice of Defense of Claims. Promptly after receipt of notice of any
claim or Damages for which an Indemnitee seeks indemnification under this
Article IX, such Indemnitee shall give written notice thereof to the
Indemnifying Party, but such notification shall not be a condition to
indemnification hereunder except to the extent of actual prejudice to the
Indemnifying Party. The notice shall state the information then available
regarding the amount and nature of such claim or Damages and shall specify the
provision or provisions of this Agreement under which the right to
indemnification is asserted. If within 30 days after receiving such notice the
Indemnifying Party gives written notice to the Indemnitee stating that it
intends to defend against such claim or Damages at its own cost and expense,
then defense of such matter, including selection of counsel (subject to the
consent of the Indemnitee which consent shall not be unreasonably withheld),
shall be by the Indemnifying Party and the Indemnitee shall make no payment in
respect of such claim or Damages as long as the Indemnifying party is conducting
a good faith and diligent defense. Notwithstanding the foregoing, the Indemnitee
shall at all times have the right to fully participate in such defense at its
own expense directly or
45
<PAGE>
through counsel; provided, however, if the named parties to the action or
proceeding include both the Indemnifying Party and the Indemnitee and
representation of both parties by the same counsel would be inappropriate under
applicable standards of professional conduct, the expenses of one separate
counsel for the Indemnitee shall be paid by the Indemnifying Party. If no such
notice of intent to dispute and defend is given by the Indemnifying Party, or if
such diligent good faith defense is not being or ceases to be conducted, the
Indemnitee shall, at the expense of the Indemnifying Party, undertake the
defense of such claim or Damages with counsel selected by the Indemnitee, and
shall have the right to compromise or settle the same exercising reasonable
business judgment with the consent of the Indemnifying Party, which consent
shall not be unreasonably withheld. The Indemnitee shall make available all
information and assistance that the Indemnifying Party may reasonably request
and shall cooperate with the Indemnifying Party in such defense. Notwithstanding
anything herein to the contrary, the Indemnifying Party shall have the right to
settle all claims of third parties for which indemnification is payable
hereunder without the consent of the Indemnitee so long as such settlement
releases the Indemnitee from all liability for or in connection with such action
and does not materially and adversely impair the ability of the Indemnitee to
carry on its business and does not contain any admission of wrong doing on the
part of the Indemnitee.
ARTICLE X
NOTICES
10.1 Notices. All notices and other communications under this Agreement
must be in writing and will be deemed to have been duly given if delivered,
telecopied or mailed, by certified mail, return receipt requested, first-class
postage prepaid, to the parties at the following addresses:
If to the Sellers, to:
c/o Leucadia National Corporation
315 Park Avenue South
New York, New York 10010
Attention: Joseph S. Steinberg, President
Telephone: (212) 460-1900
Telecopy: (212) 598-3245
46
<PAGE>
with a copy to:
Weil, Gotshal & Manges LLP
767 Fifth Avenue
New York, New York 10153
Attention: Stephen E. Jacobs, Esq.
Telephone: (212) 310-8000
Telecopy: (212) 310-8007
If to the Purchaser, to:
Conseco, Inc.
11825 N. Pennsylvania Street
Carmel, Indiana 46032
Attention: General Counsel
Telephone: (317) 817-6163
Telecopy: (317) 817-6327
All notices and other communications required or permitted under this Agreement
that are addressed as provided in this Article X will, if delivered personally,
be deemed given upon delivery, will, if delivered by telecopy, be deemed
delivered when confirmed and will, if delivered by mail in the manner described
above, be deemed given on the third business day after the day it is deposited
in a regular depository of the United States mail. Any party from time to time
may change its address for the purpose of notices to that party by giving a
similar notice specifying a new address, but no such notice will be deemed to
have been given until it is actually received by the party sought to be charged
with the contents thereof.
ARTICLE XI
MISCELLANEOUS
11.1 Entire Agreement. Except for documents executed by the parties hereto
pursuant to this Agreement and the Confidentiality Agreement, this Agreement
supersedes all prior discussions and agreements between the parties with respect
to the subject matter of this Agreement, and this Agreement (including the
exhibits hereto, the Seller Disclosure Schedule, the Purchaser Disclosure
Schedule and other documents delivered in connection herewith) and the
Confidentiality Agreement contain the sole and entire agreement between the
parties hereto with respect to the subject matter hereof. The parties agree that
any item disclosed in any section of the Seller Disclosure Schedule or the
Purchaser Disclosure Schedule, as the case may be, shall be deemed to be
disclosed for all purposes of this Agreement, notwithstanding the fact that such
item was not disclosed in any other section of the
47
<PAGE>
Seller Disclosure Schedule or the Purchaser Disclosure Schedule, as the case may
be.
11.2 Expenses. Whether or not the transactions contemplated hereby are
consummated, each of the Sellers and the Purchaser will pay its own costs and
expenses incident to preparing for, entering into and carrying out this
Agreement and the consummation of the transactions contemplated hereby.
11.3 Counterparts. This Agreement may be executed in two or more
counterparts, each of which will be deemed an original, but all of which will
constitute one and the same instrument and shall become effective when such
counterparts have been signed by each of the parties and delivered to the other
parties.
11.4 No Third Party Beneficiary. Except as otherwise provided herein, the
terms and provisions of this Agreement are intended solely for the benefit of
the parties hereto, and their respective successors or assigns, and it is not
the intention of the parties to confer third-party beneficiary rights upon any
other person.
11.5 Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware, regardless of the laws that
might otherwise govern under applicable principles of conflicts of laws thereof.
11.6 Amendments and Supplements. This Agreement may be
amended or supplemented at any time by additional written
agreements signed by the parties hereto.
11.7 Assignment; Binding Effect. Except as otherwise provided herein,
neither this Agreement nor any of the rights, interests or obligations under
this Agreement shall be assigned, in whole or in part, by operation of Law or
otherwise by any of the parties without the prior written consent of the other
parties, and any such assignment that is not consented to shall be null and
void. Subject to the preceding sentence, this Agreement will be binding upon,
inure to the benefit of and be enforceable by, the parties and their respective
successors and assigns. The Purchaser may assign its interest in this Agreement
to any direct or indirect subsidiary of the Purchaser that is designated by the
Purchaser in writing to the Sellers at or before the Closing to purchase all or
any portion of the CPL Common Stock or PLI Common Stock or to enter into the
reinsurance contracts pursuant to this Agreement, which subsidiary specifically
agrees to be bound by the terms and conditions of this Agreement or any such
agreement; provided, that, notwithstanding any such assignment, the Purchaser
shall be the maker of the Purchaser Notes and shall remain liable to perform all
obligations required to be performed hereunder and thereunder and
48
<PAGE>
provided, further, that no such assignment shall be made (a) if such assignment
shall cause the Purchaser to fail to satisfy any applicable Law of any Insurance
Regulator or other Governmental Entity or otherwise delay the consummation of
the transactions contemplated hereby or (b) that would cause the Sellers to be
unable to report gain, for income tax purposes, in respect of the sale of CPL,
on the installment method under Section 453 of the Code.
11.8 Enforcement. The parties agree that irreparable damage would occur in
the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached. It is
accordingly agreed that the parties shall be entitled to an injunction or
injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions of this Agreement, this being in addition to any other
remedy to which they are entitled at law or in equity.
11.9 Headings, Gender, etc. The headings used in this Agreement have been
inserted for convenience and do not constitute matter to be construed or
interpreted in connection with this Agreement. Unless the context of this
Agreement otherwise requires, (a) words of any gender are deemed to include each
other gender; (b) words using the singular or plural number also include the
plural or singular number, respectively; (c) the terms "hereof," "herein,"
"hereby," "hereto," and derivative or similar words refer to this entire
Agreement; (d) the terms "ARTICLE" or "Section" refer to the specified ARTICLE
or Section of this Agreement; (e) the term "party" means, on the one hand, the
Purchaser, and on the other hand, the Sellers, Leucadia Financial, Intramerica,
CPF and CPI; (f) the phrase "in the ordinary course of business and consistent
with past practice" refers to the business, operations, affairs, and practice of
the Companies consistent with past practices of such business, operations, and
affairs; (g) the phrase "to the knowledge of the Sellers" and similar phrases
mean the actual knowledge of the Directors of Leucadia or CP Holdings, the
Chairman, the President, any Executive or Senior Vice President, the Treasurer
or any Vice President of Leucadia or CP Holdings, or the Directors, the
Chairman, the President, any Executive or Senior Vice President, any Vice
President, the General Counsel, the Treasurer, or any legal compliance officer
of CPL or PLI; (h) the phrase "to the knowledge of Purchaser" and similar
phrases mean the knowledge of the Directors, the Chairman, the President, any
Executive or Senior Vice President, the General Counsel, Treasurer or any Vice
President of the Purchaser; (i) the term "person" shall include any natural
person, corporation, limited liability company, general partnership, limited
partnership, or other entity, enterprise, authority or business organization;
and
49
<PAGE>
(j) all references to "dollars" or "$" refer to currency of the
United States of America.
11.10 Invalid Provisions. If any provision of this Agreement is held to be
illegal, invalid, or unenforceable under any present or future law, and if the
rights or obligations of the Sellers, the Companies or the Purchaser under this
Agreement will not be materially and adversely affected thereby, (a) such
provision will be fully severable; (b) this Agreement will be construed and
enforced as if such illegal, invalid, or unenforceable provision had never
comprised a part hereof; and (c) the remaining provisions of this Agreement will
remain in full force and effect and will not be affected by the illegal,
invalid, or unenforceable provision or by its severance herefrom.
11.11 Revisions to Certain Exhibits. Notwithstanding anything herein to
the contrary, documents attached hereto as exhibits referenced in Sections 4.7
and 4.8 hereof shall be entered into substantially in the form as attached
hereto, with such changes thereto as any party thereto may reasonably request to
effectuate the transactions described in this Agreement in accordance with
customary practices.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
50
<PAGE>
IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by
the duly authorized officers of the Purchaser and the Sellers, effective as of
the date first written above.
CONSECO, INC.
By: /s/ ROLLIN M. DICK
---------------------------------
Name: Rollin M. Dick
Title: Executive Vice President
LEUCADIA NATIONAL CORPORATION
By: /s/ THOMAS E. MARA
---------------------------------
Name: Thomas E. Mara
Title: Executive Vice President
LEUCADIA FINANCIAL CORPORATION
By: /s/ THOMAS E. MARA
---------------------------------
Name: Thomas E. Mara
Title: Executive Vice President
COLONIAL PENN HOLDINGS INC.
By: /s/ LINDA M. DELANEY
---------------------------------
Name: Linda M. Delaney
Title: President
INTRAMERICA LIFE INSURANCE COMPANY
By: /s/ GREGORY R. BARSTEAD
---------------------------------
Name: Gregory R. Barstead
Title: President
S-1
<PAGE>
CHARTER NATIONAL LIFE INSURANCE COMPANY
By: /s/ GREGORY R. BARSTEAD
---------------------------------
Name: Gregory R. Barstead
Title: President
COLONIAL PENN GROUP, INC.
By: /s/ LINDA M. DELANEY
---------------------------------
Name: Linda M. Delaney
Title: President
COLONIAL PENN FRANKLIN INSURANCE COMPANY
By: /s/ HENRY H. WULSIN
---------------------------------
Name: Henry H. Wulsin
Title: President
COLONIAL PENN INSURANCE COMPANY
By: /s/ HENRY H. WULSIN
---------------------------------
Name: Henry H. Wulsin
Title: President
Solely with respect to the provisions
of Sections 4.5(b) and 4.11 hereof:
COLONIAL PENN LIFE INSURANCE COMPANY
By: /s/ GREGORY R. BARSTEAD
---------------------------------
Name: Gregory R. Barstead
Title: President
S-2
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This Schedule contains a summary financial information extracted from the
financial statements contained in the body of the accompanying Form 10-Q and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-END> JUN-30-1997
<CASH> 259,308
<SECURITIES> 2,350,919
<RECEIVABLES> 812,200
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 0
<PP&E> 89,392
<DEPRECIATION> 0
<TOTAL-ASSETS> 4,687,237
<CURRENT-LIABILITIES> 0
<BONDS> 579,384
0
0
<COMMON> 61,553
<OTHER-SE> 1,126,817
<TOTAL-LIABILITY-AND-EQUITY> 4,687,237
<SALES> 70,570
<TOTAL-REVENUES> 654,090
<CGS> 49,253
<TOTAL-COSTS> 445,688
<OTHER-EXPENSES> 125,167
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 24,780
<INCOME-PRETAX> 58,455
<INCOME-TAX> 21,613
<INCOME-CONTINUING> 32,976
<DISCONTINUED> 15,337
<EXTRAORDINARY> (2,044)
<CHANGES> 0
<NET-INCOME> 46,269
<EPS-PRIMARY> .76
<EPS-DILUTED> .75
</TABLE>
